JP4000125B2 - Syringe connection port - Google Patents
Syringe connection port Download PDFInfo
- Publication number
- JP4000125B2 JP4000125B2 JP2004106042A JP2004106042A JP4000125B2 JP 4000125 B2 JP4000125 B2 JP 4000125B2 JP 2004106042 A JP2004106042 A JP 2004106042A JP 2004106042 A JP2004106042 A JP 2004106042A JP 4000125 B2 JP4000125 B2 JP 4000125B2
- Authority
- JP
- Japan
- Prior art keywords
- valve
- syringe
- seal valve
- seal
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000013013 elastic material Substances 0.000 claims description 7
- 239000007924 injection Substances 0.000 description 108
- 238000002347 injection Methods 0.000 description 108
- 229920001971 elastomer Polymers 0.000 description 92
- 239000005060 rubber Substances 0.000 description 92
- 239000008280 blood Substances 0.000 description 91
- 210000004369 blood Anatomy 0.000 description 91
- 239000000126 substance Substances 0.000 description 62
- 238000001802 infusion Methods 0.000 description 57
- 230000002093 peripheral effect Effects 0.000 description 37
- 239000000243 solution Substances 0.000 description 29
- 239000003814 drug Substances 0.000 description 20
- 229940079593 drug Drugs 0.000 description 20
- 239000007788 liquid Substances 0.000 description 15
- 239000008155 medical solution Substances 0.000 description 10
- 238000007789 sealing Methods 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 6
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 230000000149 penetrating effect Effects 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 4
- 239000003978 infusion fluid Substances 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 101000793686 Homo sapiens Azurocidin Proteins 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 230000002079 cooperative effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 206010011409 Cross infection Diseases 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/22—Valves or arrangement of valves
- A61M39/24—Check- or non-return valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
- A61M2039/1083—Tube connectors; Tube couplings having a plurality of female connectors, e.g. Luer connectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
- A61M2039/1088—Tube connectors; Tube couplings having a plurality of male connectors, e.g. Luer connectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/22—Valves or arrangement of valves
- A61M39/24—Check- or non-return valves
- A61M2039/2426—Slit valve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/22—Valves or arrangement of valves
- A61M39/24—Check- or non-return valves
- A61M2039/2433—Valve comprising a resilient or deformable element, e.g. flap valve, deformable disc
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Description
本発明は、容器または配管の開口部に設けられ、ツイストロック式ニードルレス注射器を容器または配管に接続するための注射器接続ポートに関するものである。 The present invention relates to a syringe connection port that is provided in an opening of a container or a pipe and connects a twist lock type needleless syringe to the container or the pipe.
図21は、輸液用混注管を用いて血液や薬液を輸液する輸液ラインの説明図である。輸液壜または輸液バッグ100から輸液チューブ101を介して、コネクタ102に接続されたカテーテル103まで、血液や薬液が供給される。輸液チューブ101の一端には導入針104が接続され、導入針104には血液や薬液の流量を監視するドリップチャンバ(点滴筒)105が接続され、以下、コネクタ102に至るまでの輸液チューブ101に、順次、流量調節器106、所望数の混注管107、ゴミや気泡などを取り除くためのタコ管108、ゴミなどの通過を阻止するフィルタ109などを接続している(例えば、特許文献1参照。)
。
FIG. 21 is an explanatory diagram of an infusion line for transfusion of blood or chemicals using a transfusion mixed injection tube. Blood or a chemical solution is supplied from the infusion bag or infusion bag 100 to the catheter 103 connected to the connector 102 via the infusion tube 101. An infusion needle 104 is connected to one end of the infusion tube 101, and a drip chamber (infusion tube) 105 for monitoring the flow rate of blood or drug solution is connected to the infusion needle 104, and hereinafter, the infusion tube 101 up to the connector 102 is connected to the infusion tube 101. In sequence, a flow rate controller 106, a desired number of mixed injection tubes 107, an octopus tube 108 for removing dust and bubbles, a filter 109 for blocking the passage of dust and the like are connected (for example, see Patent Document 1). )
.
従来の混注管107は、例えば、図22に示すように、T字管形状をなす管本体107aの側部に形成された分岐管部分107b内に円盤状のゴム栓107cを気密に嵌合し、キャップ107dで押圧した構成からなり、管本体107aを、図21に示すように、輸液回路(例えば、人工腎臓の透析回路、点滴回路など)の輸液チューブ101の途中に挿入接続し、前記分岐管部分107bのゴム栓107cに注射器110の先端に装着した注射針110aを刺し込んで、注射器110の本体内の血液や薬液を前記輸液回路の血液や薬液に混注している(例えば、特許文献2参照。)。 For example, as shown in FIG. 22, a conventional mixed injection pipe 107 has a disk-like rubber stopper 107c fitted in a branch pipe portion 107b formed on a side portion of a T-shaped pipe main body 107a. The tube body 107a is inserted and connected in the middle of the infusion tube 101 of an infusion circuit (for example, a dialysis circuit of an artificial kidney, an infusion circuit, etc.) as shown in FIG. The injection needle 110a attached to the tip of the syringe 110 is inserted into the rubber stopper 107c of the tube portion 107b, and the blood and the drug solution in the main body of the syringe 110 are mixedly mixed with the blood and the drug solution in the infusion circuit (for example, Patent Documents). 2).
従来の混注管107は、円盤状のゴム栓107cに注射針110aを突き刺して使用するもので、注射針110aを使用する分だけコスト高となり、また、医師や看護婦が注射針110aを誤って指などに突き刺してしまい患者の血液付着による病原菌の汚染を受ける危険性があった。しかも、使用後の注射針110aは、患者の血液付着による病原菌の汚染防止のため再使用しないで廃棄しなければならず、廃品回収業者などが不用意に注射針110aによって傷付いたり、病原菌によって汚染されたりすることがないように、廃棄に十分な配慮を必要とする問題があり、また、この使用済み注射針110aの誤射等により院内感染を生じるという問題もあった。 The conventional mixed injection tube 107 is used by inserting an injection needle 110a into a disk-shaped rubber stopper 107c, and the cost is increased by the use of the injection needle 110a. Also, a doctor or a nurse mistakenly inserts the injection needle 110a. There was a risk of being pierced by a finger or the like and contaminated with pathogenic bacteria due to blood adhesion of the patient. In addition, the used injection needle 110a must be discarded without being reused to prevent contamination of pathogenic bacteria due to blood adhesion of the patient, and a waste product collector or the like is inadvertently damaged by the injection needle 110a or caused by pathogenic bacteria. There is a problem that requires sufficient consideration for disposal so as not to be contaminated, and there is also a problem that nosocomial infection occurs due to misfiring of the used injection needle 110a.
そこで、本発明者により、輸液回路の途中に注射針を使用しない、所謂、ニードルレス注射器によって、輸液回路の血液や薬液に、血液や栄養剤などの薬液を混注できる、注射器接続ポートが考えられている。この注射器接続ポートは、スリーブ部を有しないキャップによって、カット部を有する円盤状のシール弁を保持しており、シール弁とキャップとがほぼ面一状であるため、円盤状のシール弁であっても、簡単にニードルレス注射器の口部をシール弁のカット部に貫通させることができるが、注射器の口部をシール弁で確実に保持し続けることが困難である。 In view of this, the present inventors have considered a syringe connection port in which a drug solution such as blood or nutrients can be mixed with blood or drug solution in an infusion circuit by a so-called needleless syringe that does not use an injection needle in the middle of the infusion circuit. ing. This syringe connection port holds a disc-shaped seal valve having a cut portion by a cap that does not have a sleeve portion, and the seal valve and the cap are substantially flush with each other. However, although the mouth portion of the needleless syringe can be easily passed through the cut portion of the seal valve, it is difficult to reliably hold the mouth portion of the syringe with the seal valve.
そのため、本発明者によってさらに、ツイストロック式ニードルレス注射器を用いて、注射器をキャップのスリーブ部にロック可能にしたものが提案されている。ツイストロック式ニードルレス注射器は、口部の周囲にカラー部を有し、このカラー部の内面に形成した雌ねじ部を、注射器の口部を挿入するスリーブ部の外周面上端に形成した螺合片に螺合(ツイストロック)するものであるが、分岐管部分の基部に円盤状のシール弁を配置した構造では、注射器の口部をシール弁のカット部に直接貫通させることができないという問題点があった。 For this reason, the present inventor has further proposed a device in which a twist lock type needleless syringe can be used to lock the syringe to the sleeve portion of the cap. The twist lock type needleless syringe has a collar portion around the mouth portion, and a threaded piece formed at the upper end of the outer peripheral surface of the sleeve portion into which the mouth portion of the syringe is inserted with a female screw portion formed on the inner surface of the collar portion However, in the structure in which a disc-shaped seal valve is arranged at the base of the branch pipe portion, the mouth of the syringe cannot be directly passed through the cut portion of the seal valve. was there.
そこで、本発明者によりさらに、上下方向に貫通するカット部を設けた円盤状のシール弁の上にアダプタを配置しておき、このシール弁のカット部を常時は混注管の分岐管部分により圧着密閉すると共に、スリーブ部内にツイストロック式ニードルレス注射器の口部を挿入させて、その口部の先端でアダプタを押圧し、アダプタをシール弁のカット部に挿し込んで貫通させることによって、注射器内の血液や薬液を混注するようにしたニードルレス混注管も提案されている。 Therefore, the inventor further places an adapter on a disc-shaped seal valve provided with a cut portion penetrating in the vertical direction, and the cut portion of this seal valve is normally crimped by the branch pipe portion of the mixed injection pipe. While sealing, insert the mouth part of the twist lock type needleless syringe into the sleeve part, press the adapter with the tip of the mouth part, and insert the adapter into the cut part of the seal valve to penetrate it. There has also been proposed a needleless co-infusion tube that co-injects blood and chemical solutions.
しかしながら、カット部にアダプタを挿し込み貫通させて、輸液回路の血液や薬液に注射器から血液や薬液を混注するようにしたツイストロック式ニードルレス混注管は、シール弁の他にアダプタが必要であり、しかも、注射針ではなく、口径の大きい口部が貫通されるため、シール弁のカット部が大きくなり、耐圧密閉性を確保するためにも、シール弁の形状やカット部の形状に工夫を要するなど、改善の余地があった。 However, the twist lock type needleless mixed injection tube in which the adapter is inserted into the cut part and penetrated to mix blood or chemical from the syringe into the blood or chemical in the infusion circuit requires an adapter in addition to the seal valve. In addition, since the large-diameter mouth portion is penetrated instead of the injection needle, the cut portion of the seal valve becomes large, and in order to ensure pressure-tightness, the shape of the seal valve and the shape of the cut portion are devised. There was room for improvement.
本発明は、従来の上記問題点に鑑みて提案されたもので、その主たる目的は、注射針を使用しないツイストロック式ニードルレス注射器の口部をスリーブ部に挿入することによって、アダプタを使用することなく、その口部で直接シール弁を押圧変形させて弁孔を開口状態にして、輸液回路の血液や薬液に、注射器内の血液や薬液の注入が可能な注射器接続ポートを提供することにある。 The present invention has been proposed in view of the above-described problems of the prior art, and its main purpose is to use an adapter by inserting the mouth of a twist-lock needleless syringe that does not use an injection needle into the sleeve portion. To provide a syringe connection port capable of injecting blood or drug solution in a syringe into blood or drug solution in an infusion circuit by directly pressing and deforming the seal valve at its mouth to open the valve hole. is there.
本発明の従たる目的は、ツイストロック式ニードルレス注射器の口部をスリーブ部から抜取ったときに、シール弁の表面に残留する血液や薬液を空気中の細菌によって汚染させないことであり、さらには、シール弁の表面に残留する血液や薬液を拭取れるようにすることである。 A subordinate object of the present invention is to prevent contamination of blood and chemicals remaining on the surface of the seal valve with bacteria in the air when the mouth of the twist lock needleless syringe is removed from the sleeve. Is to wipe off blood and chemicals remaining on the surface of the seal valve.
上記目的を達成するため本発明の請求項1に記載の注射器接続ポートは、容器または配管の開口部に装着した、中央部に弁孔を有する弾性材料からなる略半球状のシール弁と、前記容器または配管の開口部を囲むように設け、シール弁を押圧して弁孔を圧着密閉する、ツイストロック式ニードルレス注射器の口部が挿入可能なスリーブ部と、前記ツイストロック式ニードルレス注射器の口部をスリーブに挿入した状態において、その口部の先端をシール弁に貫通させることなく、かつ、その口部の先端で直接前記シール弁を押圧変形させて、シール弁の弁孔を開口させるようにしたことを特徴とする。 In order to achieve the above object, a syringe connection port according to claim 1 of the present invention includes a substantially hemispherical seal valve made of an elastic material having a valve hole in a central portion, which is attached to an opening of a container or piping. A sleeve portion that is provided so as to surround an opening of a container or a pipe, presses a seal valve, and crimps and seals the valve hole, into which a mouth portion of a twist lock type needleless syringe can be inserted, and the twist lock type needleless syringe. In a state where the mouth portion is inserted into the sleeve, the seal valve is directly pressed and deformed at the tip end of the mouth portion without penetrating the seal valve to open the valve hole of the seal valve. It is characterized by doing so.
上記構成によれば、常時は、シール弁の弁孔がスリーブ部によって圧着密閉されており、輸液回路の内圧により、シール弁の弁孔が開くことはなく、血液や薬液が漏れることがない。また、スリーブ部にツイストロック式ニードルレス注射器の口部を挿入することによって、注射器の口部を、アダプタを介することなく直接、かつ、シール弁を貫通させることなくシール弁を押圧変形させて、その弁孔を開口させることができる。しかも、前記スリーブ部の螺合片と注射器のカラー部内周面の雌ねじ部を螺合(ツイストロック)させることによって、シール弁の弁孔が開口した状態を保持することができる。したがって、この開口された弁孔を通して、注射器内の血液や薬液を、注射器接続ポートを介して輸液回路の血液や薬液に混注することができる。なお、必要に応じて、注射器接続ポートを介して、輸液回路内の血液や薬液を注射器に抽出することができる。さらに、注射器のカラー部内面の雌ねじ部とスリーブ部の螺合片との螺合状態を解除することによって、シール弁が自己の弾性復元力で元の形状に復帰することによって、再び、シール弁の弁孔が圧着密閉されるので、血液や薬液が漏れることがない。また、略半球状のシール弁は、スリーブの基部に装着された円盤状のシール弁に比較して、スリーブ部内におけるその頭部位置が高いため、スリーブ部内へのツイストロック式ニードルレス注射器の口部の挿入によって、直接、すなわち、アダプタを介することなく、シール弁を押圧変形させて、弁孔を確実に開口させることができると共に、注射器の口部による押圧力を解除した際の弾性復元性に優れており、シール弁の弁孔を確実に圧着密閉して、血液や薬液の漏れを防止することができる。また、血液や薬液の内圧による変形に対して、シール弁の内方側において弁孔を閉止する方向の力が作用するので、内圧による血液や薬液の漏れを確実に防止することができる。 According to the above configuration, the valve hole of the seal valve is normally crimped and sealed by the sleeve portion, and the valve hole of the seal valve does not open due to the internal pressure of the infusion circuit, so that blood and chemicals do not leak. In addition, by inserting the mouth of the twist lock type needleless syringe into the sleeve, the mouth of the syringe can be directly deformed without passing through the adapter and the seal valve can be pressed and deformed, The valve hole can be opened. Moreover, the state in which the valve hole of the seal valve is opened can be maintained by screwing (twist-locking) the threaded piece of the sleeve part and the female threaded part of the inner peripheral surface of the collar part of the syringe. Therefore, the blood and the drug solution in the syringe can be mixed and injected into the blood and the drug solution in the infusion circuit through the syringe connection port through the opened valve hole. In addition, the blood and the chemical | medical solution in an infusion circuit can be extracted to a syringe via a syringe connection port as needed. Furthermore, by releasing the screwed state between the female threaded portion on the inner surface of the collar portion of the syringe and the screwed piece of the sleeve portion, the seal valve returns to its original shape with its own elastic restoring force, so that the seal valve again. Since the valve hole is sealed by pressure, blood and chemicals do not leak. In addition, the substantially hemispherical seal valve has a higher head position in the sleeve portion than the disc-shaped seal valve attached to the base portion of the sleeve, so the mouth of the twist-lock type needleless syringe into the sleeve portion. By inserting the part, the seal valve can be pressed and deformed directly, that is, without using an adapter, and the valve hole can be opened reliably, and the elastic resilience when the pressing force by the mouth of the syringe is released The valve hole of the seal valve can be reliably crimped and sealed to prevent leakage of blood or chemicals. Moreover, since the force in the direction of closing the valve hole acts on the inner side of the seal valve against the deformation due to the internal pressure of the blood or the chemical liquid, it is possible to reliably prevent the leakage of the blood or the chemical liquid due to the internal pressure.
本発明の請求項2に記載の注射器接続ポートは、前記シール弁が、その弁孔の周囲にリング部および凹部のいずれか一方または両方を有することを特徴とする。 The syringe connection port according to claim 2 of the present invention is characterized in that the seal valve has one or both of a ring portion and a recess around the valve hole.
上記構成によれば、常時は、シール弁の弁孔が自己の弾性力によって圧着密閉されており、血液や薬液の漏れをなくすことができる。また、ツイストロック式ニードルレス注射器の口部を、シール弁に当接させてシール弁を押圧変形させることによって、シール弁の弁孔を開口させることができ、この開口した弁孔を通して、輸液回路の血液や薬液に注射器内の血液や薬液を混注することができる。このとき、シール弁は、弁孔の周囲にリング部および凹部のいずれか一方または両方を設けたことによって、シール弁の弁孔が開口し易くなっているので、スリーブ部内に注射器の口部を挿入したときに、弁孔を確実に開口させることができる。さらに、スリーブ部の螺合片と注射器のカラー部内の雌ねじ部とを螺合を解除することによって、シール弁の弁孔が再び圧着密閉されるので、血液や薬液の漏れが防止できる。 According to the above configuration, the valve hole of the seal valve is normally crimped and sealed by its own elastic force, and it is possible to eliminate leakage of blood and chemicals. Further, the valve portion of the seal valve can be opened by bringing the mouth portion of the twist lock type needleless syringe into contact with the seal valve to press and deform the seal valve, and the infusion circuit can be opened through the opened valve hole. The blood and drug solution in the syringe can be mixed with the blood and drug solution. At this time, since the seal valve is provided with either or both of the ring portion and the recess around the valve hole, the valve hole of the seal valve is easily opened. When inserted, the valve hole can be reliably opened. Further, by releasing the screwing of the screwed piece of the sleeve part and the female screw part in the collar part of the syringe, the valve hole of the seal valve is again crimped and sealed, so that leakage of blood and chemicals can be prevented.
本発明の請求項1の注射器接合ポートによれば、上部の中央部に弁孔を有する弾性材料からなるシール弁と、前記容器または配管の開口部を囲むように設け、シール弁を押圧して弁孔を圧着密閉する、ツイストロック式ニードルレス注射器の口部が挿入可能なスリーブ部と、前記ツイストロック式ニードルレス注射器の口部をスリーブに挿入した状態において、その口部の先端をシール弁に挿し込み貫通させることなく、かつ、その口部の先端で直接前記シール弁を押圧変形させて、シール弁の弁孔を開口させるようにしたので、常時は、シール弁の弁孔が圧着密閉されており、輸液回路の内圧により、シール弁の弁孔が開くことはなく、血液や薬液が漏れることがない。また、スリーブ部に注射器を螺合(ツイストロック)させることによって、アダプタを介することなく直接、かつ、注射器の口部を前記シール弁の弁孔に挿し込み貫通させることなく、シール弁を押圧変形させて、その弁孔を開口させることができる。しかも、前記スリーブ部と注射器とを螺合させることによって、シール弁の弁孔が開口した状態を保持することができる。したがって、この開口された弁孔を通して、注射器内の血液や薬液を、注射器接続ポートを介して輸液回路の血液や薬液に混注することができる。なお、必要に応じて、注射器接続ポートを介して、輸液回路内の血液や薬液を注射器に抽出することができる。さらに、注射器とスリーブ部との螺合状態を解除することによって、シール弁が自己の弾性復元力で元の形状に復帰して、再び、シール弁の弁孔が圧着密閉されるので、血液や薬液が漏れることがない。また、注射器の口部を弁孔に挿し込み貫通させないので、スリーブ部から抜取った注射器の口部の外周面に血液や輸液が付着しておらず衛生的である。また、前記シール弁が略半球状であるから、円盤状のシール弁に比較して、スリーブ部内へのツイストロック式ニードルレス注射器の口部の挿入によって、直接、すなわち、アダプタを介することなく、しかも、注射器の口部をシール弁の弁孔に挿し込み貫通させることなくシール弁を押圧変形させて、弁孔を確実に開口させることができると共に、注射器の口部による押圧力を解除した際の弾性復元性に優れており、シール弁の弁孔を確実に圧着密閉して、血液や薬液の漏れを防止することができる。 According to the syringe joint port of the first aspect of the present invention, a seal valve made of an elastic material having a valve hole at the center of the upper portion and the opening of the container or pipe are provided so as to surround the seal valve, A sleeve portion that can be inserted and sealed with a twist lock type needleless syringe that seals the valve hole, and a seal valve that seals the tip of the mouth portion when the mouth portion of the twist lock type needleless syringe is inserted into the sleeve. The seal valve is pressed and deformed directly at the end of its mouth without being inserted into the valve, so that the valve hole of the seal valve is opened. In addition, the valve hole of the seal valve does not open due to the internal pressure of the infusion circuit, and blood and chemicals do not leak. In addition, by screwing the syringe into the sleeve (twist lock), the seal valve is pressed and deformed directly without going through the adapter, and without inserting and penetrating the mouth of the syringe into the valve hole of the seal valve. The valve hole can be opened. Moreover, the state in which the valve hole of the seal valve is opened can be maintained by screwing the sleeve portion and the syringe. Therefore, the blood and the drug solution in the syringe can be mixed and injected into the blood and the drug solution in the infusion circuit through the syringe connection port through the opened valve hole. In addition, the blood and the chemical | medical solution in an infusion circuit can be extracted to a syringe via a syringe connection port as needed. Furthermore, by releasing the screwed state between the syringe and the sleeve portion, the seal valve returns to its original shape by its own elastic restoring force, and the valve hole of the seal valve is again crimped and sealed. There is no leakage of chemicals. Further, since the mouth portion of the syringe is not inserted through the valve hole and penetrated, the blood and the infusion are not attached to the outer peripheral surface of the mouth portion of the syringe extracted from the sleeve portion, which is sanitary. Further, since the seal valve is substantially hemispherical, compared to a disc-shaped seal valve, by inserting the mouth of the twist lock type needleless syringe into the sleeve portion directly, that is, without using an adapter, Furthermore, when the mouth of the syringe is inserted into the valve hole of the seal valve and the seal valve is pressed and deformed without being penetrated, the valve hole can be opened reliably, and the pressing force by the mouth of the syringe is released. It is possible to prevent leakage of blood and chemicals by securely pressing and sealing the valve hole of the seal valve.
本発明の請求項2に記載の注射器接続ポートは、前記シール弁が、その弁孔の周囲にリング部および凹部のいずれか一方または両方を設けたので、常時は、シール弁の弁孔が圧着密閉されており、血液や薬液の漏れをなくすことができる。また、ツイストロック式ニードルレス注射器の口部を、シール弁に当接させてシール弁を押圧変形させることによって、シール弁の弁孔をより容易、かつ、確実に開口させることができ、この開口した弁孔を通して、輸液回路の血液や薬液に注射器内の血液や薬液を混注することができる。 In the syringe connection port according to claim 2 of the present invention, since the seal valve is provided with one or both of a ring portion and a recess around the valve hole, the valve hole of the seal valve is normally crimped. It is sealed and can prevent blood and chemicals from leaking. Further, the opening of the seal valve can be more easily and reliably opened by bringing the mouth of the twist lock type needleless syringe into contact with the seal valve and pressing and deforming the seal valve. Through the valve hole, the blood or drug solution in the syringe can be mixed and mixed with the blood or drug solution in the infusion circuit.
以下、本発明の注射器接続ポートを各種の混注管に適用した実施形態について、図面を参照して説明する。 Hereinafter, embodiments in which the syringe connection port of the present invention is applied to various mixed injection tubes will be described with reference to the drawings.
第1の実施形態の混注管1は、図1の(A)(B)に示すように、両端に輸液チューブ接続口11,12を備え、これらの輸液チューブ接続口11,12間に連通したルーメンを有するT字管形状をなす管本体10と、この管本体10の側部に形成され前記ルーメンと連通するルーメンを有する分岐管部分13とを有し、分岐管部分13内に、上面の凹部20aに弁孔20bを上下方向に貫通して形成した弾性体材料からなる外方に凸の半球状のシール弁20を気密に嵌合し、キャップ30で押圧固定して構成されている。 As shown in FIGS. 1A and 1B, the mixed injection tube 1 of the first embodiment includes infusion tube connection ports 11 and 12 at both ends, and communicates between these infusion tube connection ports 11 and 12. A pipe main body 10 having a T-shaped tube shape having a lumen, and a branch pipe portion 13 having a lumen formed on a side portion of the pipe main body 10 and communicating with the lumen; An outwardly convex hemispherical seal valve 20 made of an elastic material formed by penetrating the valve hole 20b in the up-down direction through the recess 20a is hermetically fitted and pressed and fixed with a cap 30.
前記分岐管部分13は、管本体10に対して、その強度を損なわない範囲で、管本体10の一部を薄肉部10aにして、その高さ寸法が小さくなるようにしている。また、シール弁20の下端を、鍔部10bで支持している。 The branch pipe portion 13 is formed so that a part of the pipe body 10 is a thin-walled portion 10a within a range that does not impair the strength of the pipe body 10, and the height dimension thereof is reduced. Further, the lower end of the seal valve 20 is supported by the flange portion 10b.
前記管本体10,分岐管部分13およびスリーブ部30cは、高分子樹脂材料、例えば、ポリアミド、ポリ塩化ビニル、ポリプロピレン、ポリウレタン、ポリカーボネート、ポリエチレンなどで構成されている。 The tube main body 10, the branch tube portion 13 and the sleeve portion 30c are made of a polymer resin material such as polyamide, polyvinyl chloride, polypropylene, polyurethane, polycarbonate, polyethylene or the like.
前記シール弁20は、弾性体材料、例えば、シリコンゴム、天然ゴム、ポリウレタン、軟質ポリ塩化ビニル、スチレン−ブタジエン系共重合体、アクリロニトリル−ブタジエン共重合体、ポリイソプレンなどの高分子材料で構成されている。そして、外方(図の上方)に向かって凸の半球状のものであり、その頭部には、後述するツイストロック式ニードルレス注射器(以下、注射器という)40の口部44またはゴム弁カバー50を受入れる凹部からなる受部20aを有し、この受部20aの中央部にスリットからなる弁孔20bが貫通形成されている。この弁孔20bは、スリット以外にも平面視形状が丸状,十文字状などの任意形状で、断面形状がV字状、逆V字状、円錐状、逆円錐状、凸状、逆凸状などの任意形状で、上下方向に貫通して形成することが可能である。この弁孔20bは、例えばシール弁20の成形後に直線状や円錐状の弁孔形成工具などを突き刺して形成することができるが、シール弁20の成形時に同時に形成することもできる。 The seal valve 20 is made of an elastic material, for example, a polymer material such as silicon rubber, natural rubber, polyurethane, soft polyvinyl chloride, styrene-butadiene copolymer, acrylonitrile-butadiene copolymer, polyisoprene. ing. And it is hemispherical convex outward (upward in the figure), and has a head 44 or a rubber valve cover of a twist lock type needleless syringe (hereinafter referred to as a syringe) 40 described later on its head. 50 has a receiving portion 20a made of a recess for receiving 50, and a valve hole 20b made of a slit is formed through the central portion of the receiving portion 20a. In addition to the slit, the valve hole 20b has an arbitrary shape such as a round shape or a cross shape in a plan view, and a cross-sectional shape of a V shape, an inverted V shape, a conical shape, an inverted conical shape, a convex shape, or an inverted convex shape. It is possible to form by penetrating in the up-down direction in any shape such as. The valve hole 20b can be formed, for example, by piercing a linear or conical valve hole forming tool after the sealing valve 20 is formed, but can also be formed at the same time as the sealing valve 20 is formed.
前記分岐管部分13の上端外周面には、係合用の凸部13aが設けられている。また、キャップ30は、断面形状が略T字形状をなし、上記分岐管部分13への係合部分となる下端内周面に、係合用の凸部30aが設けてあると共に、半球状のシール弁20が当接する内面に凹円弧状部30bが設けてあり、さらに、円筒状のスリーブ部30cの外周面上端には、注射器40のカラー部45の雌ねじ部46が螺合する螺合片30dが突設してある。また、スリーブ部30c内に注射器40の口部44を挿入したときに、口部44の挿入量が所定値になるようにDIN規格によって設定されているので、スリーブ部30cの高さ寸法は、その規格値以上になっている。 An engaging convex portion 13 a is provided on the outer peripheral surface of the upper end of the branch pipe portion 13. The cap 30 has a substantially T-shaped cross section, and has an engagement convex portion 30a provided on the inner peripheral surface of the lower end serving as an engagement portion with the branch pipe portion 13, and a hemispherical seal. A concave arcuate portion 30b is provided on the inner surface with which the valve 20 abuts, and a threaded piece 30d into which the female thread portion 46 of the collar portion 45 of the syringe 40 is screwed onto the upper end of the outer peripheral surface of the cylindrical sleeve portion 30c. Is protruding. Further, when the mouth portion 44 of the syringe 40 is inserted into the sleeve portion 30c, the insertion amount of the mouth portion 44 is set according to the DIN standard so that the height dimension of the sleeve portion 30c is The standard value is exceeded.
なお、前記シール弁20の凸円弧状周面部における任意の位置の外径寸法D1(図示省
略)を、キャップ30の凹円弧状部30bにおける対応位置の内径寸法D2(図示省略)
より大径として(D1>D2)、所定の締め代(D1−D2)を具備させ、このシール弁20
をスリーブ部30c内に配置して、キャップ30を分岐管部分13に装着することによって、前記シール弁20にキャップ30による圧縮力を作用させて、常時は、弁孔20bを圧着密閉状態にするようにしている。
The outer diameter D 1 (not shown) at an arbitrary position on the convex arc-shaped peripheral surface portion of the seal valve 20 is changed to the inner diameter D 2 (not shown) at the corresponding position on the concave arc-shaped portion 30b of the cap 30.
A larger diameter (D 1 > D 2 ) and a predetermined tightening allowance (D 1 -D 2 ) are provided.
Is placed in the sleeve portion 30c, and the cap 30 is mounted on the branch pipe portion 13, so that the compression force of the cap 30 is applied to the seal valve 20, and the valve hole 20b is normally in a pressure-tight sealed state. Like that.
ここで、半球状のシール弁20は、円盤状のシール弁に比較して、シール弁20に血液や薬液の内圧がかかると外方に向かって膨出するように変形するが、この変形によって弁孔20bの下端が閉じられるような力が作用するので、血液や薬液の内圧によって弁孔20bから輸液が漏出することがない。さらに、半球状のシール弁20は、円盤状のシール弁に比較して、その頭部の高さ位置が高くなるので、後述するスリーブ部内に注射器40の口部44を挿入すると、アダプタを介することなく、直接シール弁20を押圧して変形させることが可能であり、確実に弁孔20bを開口させることができる。 Here, the hemispherical seal valve 20 is deformed so as to bulge outward when the internal pressure of blood or a chemical solution is applied to the seal valve 20 as compared with the disk-shaped seal valve. Since a force that closes the lower end of the valve hole 20b acts, the infusion solution does not leak from the valve hole 20b due to the internal pressure of blood or chemicals. Furthermore, since the hemispherical seal valve 20 has a higher head height than the disc-shaped seal valve, when the mouth portion 44 of the syringe 40 is inserted into a sleeve portion described later, the adapter is interposed. The seal valve 20 can be directly pressed and deformed without any problem, and the valve hole 20b can be reliably opened.
以上のような分岐管部分13内にシール弁20を液密に配置させた構成を有する混注管1の管本体10の輸液チューブ接続口11,12に、輸液回路の輸液チューブを挿入接続
して、混注管1を輸液回路の途中に挿入接続する。なお、輸液チューブ接続口11,12
への輸液チューブの挿入接続は、接着剤を用いて行なってもよいし、輸液チューブの弾性力を利用して、単に圧入するだけでもよい。
An infusion tube of an infusion circuit is inserted and connected to the infusion tube connection ports 11 and 12 of the tube body 10 of the mixed injection tube 1 having a configuration in which the seal valve 20 is liquid-tightly arranged in the branch pipe portion 13 as described above. The mixed injection tube 1 is inserted and connected in the middle of the infusion circuit. Infusion tube connection ports 11 and 12
The infusion tube may be inserted and connected with an adhesive, or may be simply press-fitted using the elastic force of the infusion tube.
図2は、上記の混注管1に螺合される注射器40を示す。この注射器40は、注射器本体41と、押子42とで構成される。注射器本体41は、押子42が挿入されるシリンダ部43と、シリンダ部43の先端から円筒状または雄テーパ状に突出した口部44と、口部44の周りに円筒状に立設したカラー部45と、カラー部45の内周面に形成した雌ねじ部46と、シリンダ部43の後端に形成された鍔部47とを有する。押子42は横断面形状が+字状で、先端にシリンダ部43の内面と気密および液密に摺動可能な膨出部48と、後端に押圧力を掛け易くする鍔部49とを有する。なお、前記口部44は、図示するように、カラー部45よりも所定寸法だけ突出している。 FIG. 2 shows a syringe 40 screwed onto the mixed injection tube 1 described above. The syringe 40 includes a syringe body 41 and a pusher 42. The syringe main body 41 includes a cylinder portion 43 into which the pusher 42 is inserted, a mouth portion 44 protruding in a cylindrical shape or a male taper shape from the tip of the cylinder portion 43, and a collar erected in a cylindrical shape around the mouth portion 44. A portion 45, a female screw portion 46 formed on the inner peripheral surface of the collar portion 45, and a flange portion 47 formed at the rear end of the cylinder portion 43. The pusher 42 has a + -shaped cross section, and has a bulging portion 48 that can slide in an airtight and liquid-tight manner on the inner surface of the cylinder portion 43 at the tip, and a flange portion 49 that makes it easy to apply a pressing force to the rear end. Have. The mouth portion 44 protrudes by a predetermined dimension from the collar portion 45 as shown in the figure.
そして、キャップ30のスリーブ部30c内に、注射器40の口部44を挿入して、注射器40のカラー部45の内面に形成した雌ねじ部46を、スリーブ部30cの外周面上端に形成した螺合片30dに螺合させていくと、注射器40の口部44の先端部で直接シール弁20を押圧して、シール弁20が変形していき、図1(B)に示すように、雌ねじ部46と螺合片30dとを完全な螺合状態(ツイストロック)にすることによって、シール弁20の弁孔20bを開口させると共に、スリーブ部30cに注射器40が保持されて弁孔20bの開口状態を維持できる。次いで、注射器40の押子42をシリンダ部43内に押込むことによって、シリンダ部43内の血液や薬液を、混注管1を介して輸液回路の血液や薬液に混注することができる。なお、必要に応じて、混注管1を介して輸液回路の血液や薬液を注射器40のシリンダ部43内に抽出することもできる。 Then, the mouth portion 44 of the syringe 40 is inserted into the sleeve portion 30c of the cap 30, and the female screw portion 46 formed on the inner surface of the collar portion 45 of the syringe 40 is formed on the upper end of the outer peripheral surface of the sleeve portion 30c. When screwed into the piece 30d, the seal valve 20 is pressed directly at the tip of the mouth portion 44 of the syringe 40, and the seal valve 20 is deformed. As shown in FIG. 46 and the screwing piece 30d are brought into a completely screwed state (twist lock), whereby the valve hole 20b of the seal valve 20 is opened, and the syringe 40 is held by the sleeve portion 30c so that the valve hole 20b is opened. Can be maintained. Next, by pushing the pusher 42 of the syringe 40 into the cylinder portion 43, the blood and the chemical solution in the cylinder portion 43 can be mixed and injected into the blood and the chemical solution in the infusion circuit via the mixed injection tube 1. In addition, the blood and the chemical | medical solution of an infusion circuit can also be extracted in the cylinder part 43 of the syringe 40 through the mixed injection tube 1 as needed.
上記第1の実施形態における受部20aを有するシール弁20に代えて、図3(A)に示す半球状のシール弁21のように、頭部に注射器40の口部44を当接するための、所定高さのリング部21dおよび所定深さの凹部21eを設けてもよい。あるいは、図3(B)に示す略半球状のシール弁22のように、頭部近傍の半球状の外周部を球面から円錐形状に近い形状にして、頭部に注射器40の口部44を当接するための、所定高さの平坦部22dおよび所定深さの凹部22eを設けてもよい。 Instead of the seal valve 20 having the receiving portion 20a in the first embodiment, as in the hemispherical seal valve 21 shown in FIG. A ring portion 21d having a predetermined height and a recess 21e having a predetermined depth may be provided. Alternatively, like the substantially hemispherical seal valve 22 shown in FIG. 3B, the hemispherical outer peripheral portion in the vicinity of the head is formed into a shape close to a conical shape from the spherical surface, and the mouth portion 44 of the syringe 40 is formed in the head. You may provide the flat part 22d of predetermined height and the recessed part 22e of predetermined depth for contact | abutting.
図3(A)に示すシール弁21のように、頭部に所定高さのリング部21dを設けた場合は、このリング部21dの高さ寸法相当分だけ、注射器40の口部44によってシール弁21がより下方に押し下げられ、しかも、凹部21eが設けられていると、弁孔21b部分の肉厚寸法が減少する。それらの協働作用によって、注射器40の口部44でリング部21dを押圧してシール弁21を変形させると、シール弁21のリング部21dには、図示矢印a方向の、弁孔21bを締付ける力が作用すると共に、シール弁21の下面では、図示矢印b方向の、弁孔21bを開口する力が作用する。注射器40の口部44をさらに押込むと、上記の図示矢印a方向の力は、弁孔21bの上端によって受止められ、図示矢印b方向の力のみが作用して、梃子の原理およびシール弁21の弁孔21b部分の肉厚寸法が凹部21eによって小さくなっていることによって、弁孔21bがますます開口される。注射器40がスリーブ部30cにツイストロックされると、シール弁21が大きく変形して、弁孔21bの上端部も開口する。混注管1内の血液や薬液による、図示矢印c方向の内圧に対する耐内圧性は、注射器40の口部44による矢印d方向の押圧力によるリング部21dの変形制御により大きくすることができる。すなわち、このシール弁21では、リング部21dと凹部21eとの協働作用によって、図1のシール弁20よりも弁孔21bを確実に開口することができる。なお、リング部21dおよび凹部21eの両方を設けるようにした場合が最も優れた開口動作が得られるが、そのいずれか一方のみを設けるようにしてもよい。 When a ring portion 21d having a predetermined height is provided on the head like the seal valve 21 shown in FIG. 3 (A), the seal portion 21 is sealed by the mouth portion 44 of the syringe 40 by an amount corresponding to the height dimension of the ring portion 21d. When the valve 21 is pushed down further and the recess 21e is provided, the thickness of the valve hole 21b is reduced. When the ring portion 21d is pressed by the mouth portion 44 of the syringe 40 and the seal valve 21 is deformed by the cooperative action, the valve hole 21b in the direction of the arrow a is tightened on the ring portion 21d of the seal valve 21. A force is applied, and a force for opening the valve hole 21b in the direction of the arrow b is applied to the lower surface of the seal valve 21. When the mouth 44 of the syringe 40 is further pushed in, the force in the direction of the arrow a shown above is received by the upper end of the valve hole 21b, and only the force in the direction of the arrow b acts to Since the thickness dimension of the 21 valve hole 21b part is made small by the recessed part 21e, the valve hole 21b is opened more and more. When the syringe 40 is twist-locked to the sleeve portion 30c, the seal valve 21 is greatly deformed and the upper end portion of the valve hole 21b is also opened. The internal pressure resistance against the internal pressure in the direction indicated by the arrow c due to the blood or chemical in the mixed injection tube 1 can be increased by controlling the deformation of the ring portion 21d by the pressing force in the direction indicated by the arrow d by the mouth 44 of the syringe 40. That is, in this seal valve 21, the valve hole 21b can be opened more reliably than the seal valve 20 of FIG. 1 by the cooperative action of the ring portion 21d and the recess 21e. Although the most excellent opening operation can be obtained when both the ring portion 21d and the concave portion 21e are provided, only one of them may be provided.
また、図3(B)に示すシール弁22のように、頭部近傍の外周面を円錐形状に近い形状にして平坦部22dを設けると共に、凹部22eを設けた場合は、その平坦部22dの高さ位置がリング部21dを設けた場合と同様に高くなり、しかも凹部22eを設けたことによって、弁孔22b部分の肉厚寸法が減少することによって、前記図3(A)のシール弁21と同様に、平坦部22bと凹部22eとの協働作用によって、弁孔22bがより確実に開口される。混注管1内の血液や薬液による、図示矢印c方向の内圧に対する耐内圧性は、注射器40の口部44による矢印d方向の押圧力による平坦部22eの変形制御により大きくすることができる。ただし、このシール弁22は、図3(A)のリング部21dを設けた場合に比較すると、シール弁22の頭部の肉厚寸法が大きくなる分だけ、シール弁22の変形が小さくなって、弁孔22bの開口し易さが若干低下する。 Further, as in the case of the seal valve 22 shown in FIG. 3B, when the outer peripheral surface near the head is formed in a shape close to a conical shape and the flat portion 22d is provided, and the concave portion 22e is provided, the flat portion 22d The height position is increased in the same manner as when the ring portion 21d is provided, and the thickness of the valve hole 22b is reduced by providing the recess 22e, whereby the seal valve 21 shown in FIG. Similarly, the valve hole 22b is more reliably opened by the cooperative action of the flat portion 22b and the concave portion 22e. The internal pressure resistance against the internal pressure in the direction indicated by the arrow c due to the blood or chemical in the mixed injection tube 1 can be increased by controlling the deformation of the flat portion 22e by the pressing force in the direction indicated by the arrow d by the mouth portion 44 of the syringe 40. However, as compared with the case where the ring portion 21d of FIG. 3A is provided, the seal valve 22 is less deformed because the thickness of the head portion of the seal valve 22 is larger. The ease of opening the valve hole 22b is slightly reduced.
上記図1,図3に示す第1の実施形態および変形例の混注管1においては、常時は、前述のように、シール弁20,21,22の弾性力およびキャップ30から受ける締付圧によって、弁孔20b(21b,22bも同様であるので、以下、弁孔20bとする)を圧着密閉して、血液や薬液が漏出しないようにできる。また、注射器40のカラー部45をスリーブ部の螺合片30dに螺合状態(ツイストロック)にすることによって、注射器40の口部44がシール弁20,21,22の弁孔20bを貫通することなくシール弁20,21,22を押圧変形させ、弁孔20bを開口させて、注射器40内の血液や薬液を輸液回路の血液や薬液に混注したり、必要に応じて、輸液回路の血液や薬液を注射器40内に抽出したりすることができる。さらに、注射器40とスリーブ部30cとの螺合状態を解除すると、シール弁20,21,22の弾性復元力によって、シール弁20が図1(A)、図3(A)(B)に示す元の半球状や略半球状に復元して、弁孔20bをキャップ30から受ける締付力で再び圧着密閉させて、血液や薬液の漏れを防止することができる。 In the mixed injection pipe 1 according to the first embodiment and the modification shown in FIGS. 1 and 3, the elastic force of the seal valves 20, 21 and 22 and the tightening pressure received from the cap 30 are always used as described above. The valve hole 20b (21b, 22b is also the same, and hereinafter referred to as the valve hole 20b) can be crimped and hermetically sealed to prevent blood or chemicals from leaking out. Further, the collar portion 45 of the syringe 40 is screwed into a screwed piece 30d of the sleeve portion (twist lock), so that the mouth portion 44 of the syringe 40 penetrates the valve holes 20b of the seal valves 20, 21, and 22. The seal valves 20, 21, and 22 are pressed and deformed, the valve hole 20 b is opened, and blood or chemical liquid in the syringe 40 is mixed with blood or chemical liquid in the infusion circuit, or blood in the infusion circuit as necessary. Or the drug solution can be extracted into the syringe 40. Further, when the screwed state of the syringe 40 and the sleeve portion 30c is released, the seal valve 20 is shown in FIGS. 1A, 3A, and 3B by the elastic restoring force of the seal valves 20, 21, and 22. The original hemispherical shape or substantially hemispherical shape can be restored, and the valve hole 20b can be crimped and sealed again with the tightening force received from the cap 30 to prevent blood and chemicals from leaking.
上記第1の実施形態および変形例の混注管1において、キャップ30のスリーブ部30cから注射器40の口部44を抜取ったときに、シール弁20,21,22の上面に、注射器40内または混注管1内の血液や薬液が若干残留する可能性がある。もし、シール弁20の上面に、注射器40内または混注管1内の血液や薬液が若干量でも残留しそれを放置しておくと、この残留血液や薬液が空気中に浮遊する細菌などによって汚染されたり、乾燥固化したりする。すると、次に、注射器40で血液や薬液を混注しようとする際や、注射器40で血液や薬液を抽出しようとする際に、注射器40の口部44によって、細菌に汚染され、あるいは乾燥固化した血液や薬液が、輸液回路内の血液や薬液に混ざり、患者の血管内に注入される恐れがある。 In the mixed injection tube 1 of the first embodiment and the modified example, when the mouth portion 44 of the syringe 40 is extracted from the sleeve portion 30c of the cap 30, the inside of the syringe 40 or on the upper surface of the seal valves 20, 21, 22 There is a possibility that some blood and chemicals in the mixed injection tube 1 remain. If a small amount of blood or drug solution in the syringe 40 or the mixed injection tube 1 remains on the upper surface of the seal valve 20 and is left to stand, the residual blood or drug solution is contaminated by bacteria floating in the air. Or dried and solidified. Then, when blood or a drug solution is mixed with the syringe 40 or when blood or a drug solution is extracted with the syringe 40, the mouth 44 of the syringe 40 is contaminated with bacteria or dried and solidified. There is a risk that blood and chemicals may mix with blood and chemicals in the infusion circuit and be injected into the patient's blood vessels.
したがって、注射器40を抜取った後に、シール弁20の上面に血液や薬液が残留している場合は、残留した血液や薬液を、空気に触れさせないか、アルコールを含ませたガーゼや綿などで拭取っておく必要がある。ところが、上記第1の実施形態および変形例の混注管1においては、シール弁20,21,22の頭部がスリーブ部30cの内奥部に在るため、シール弁20,21,22の上面に残留した血液や薬液を拭取ることが困難であり、この点の改善が望まれる。この要望を満たすことが、先に述べたように、本発明の従たる目的である。 Therefore, if blood or chemical liquid remains on the upper surface of the seal valve 20 after the syringe 40 is removed, do not let the remaining blood or chemical liquid come into contact with air or use gauze or cotton containing alcohol. It is necessary to wipe off. However, in the mixed injection pipe 1 of the first embodiment and the modified example, since the heads of the seal valves 20, 21, 22 are in the inner part of the sleeve portion 30c, the top surfaces of the seal valves 20, 21, 22 It is difficult to wipe off blood and chemicals remaining on the skin, and improvement of this point is desired. Satisfying this need is a subordinate objective of the present invention, as described above.
第2の実施形態の混注管1aは、上記の要望を満たすように改善したもので、図4の(A)に示すように、図1(A)と同様の弾性体材料からなる半球状の頭部に受部20aを形成し、この受部20aに弁孔20bを形成したシール弁20の受部20a上に、前述と同様のシリコンゴムなどの弾性体材料からなるゴム弁カバー50を配置したものである。このゴム弁カバー50は、縦断面形状が鼓状の立脚部50aと、外方(図示上方)に向かって凸の半球状で、例えば、厚さ寸法が0.3mm程度の頭部50bとを一体に有し、その頭部50bの中央部に、貫通孔50cが形成されている。ただし、ゴム弁カバー50の貫通孔50cを、シール弁20の弁孔20bと同一の形状にすることは、必要ではなく、単に、常時は閉鎖状であり、注射器40の口部44で押圧変形された際に、開口するものであれば任意の形状でよい。ここで、「閉鎖状」とは、シール弁20の弁孔20bように、血液や薬液の内圧によって血液や薬液の漏れを阻止する耐内圧性を要求されるものではないことを意味する。 The mixed injection tube 1a of the second embodiment is improved so as to satisfy the above-mentioned demand. As shown in FIG. 4A, a hemispherical material made of an elastic material similar to that shown in FIG. A rubber valve cover 50 made of an elastic material such as silicon rubber similar to that described above is disposed on the receiving part 20a of the seal valve 20 in which the receiving part 20a is formed in the head part and the valve hole 20b is formed in the receiving part 20a. It is a thing. The rubber valve cover 50 includes a standing leg portion 50a having a drum-like longitudinal cross-section and a hemispherical shape convex outward (upward in the figure), for example, a head portion 50b having a thickness dimension of about 0.3 mm. A through hole 50c is formed at the center of the head 50b. However, it is not necessary to make the through hole 50c of the rubber valve cover 50 the same shape as the valve hole 20b of the seal valve 20, but it is simply closed at all times, and is pressed and deformed at the mouth 44 of the syringe 40. Any shape can be used as long as it is opened. Here, “closed” means that the internal pressure resistance that prevents leakage of blood or chemical liquid by the internal pressure of blood or chemical liquid is not required, unlike the valve hole 20 b of the seal valve 20.
ゴム弁カバー50の立脚部50aの下端は、シール弁20の受部20bに嵌合されているので、ゴム弁カバー50の位置決めが容易になる。シール弁20の受部20bとゴム弁カバー50の立脚部50aの下端とは、接着剤などによって接着してもよいが、単に、当接させておくのみでもよい。なお、シール弁20の受部20aの大きさは、ゴム弁カバー51における立脚部50aの下端の外形寸法に応じて、小さくしてもよい。 Since the lower end of the standing leg portion 50a of the rubber valve cover 50 is fitted to the receiving portion 20b of the seal valve 20, the positioning of the rubber valve cover 50 is facilitated. The receiving portion 20b of the seal valve 20 and the lower end of the standing leg portion 50a of the rubber valve cover 50 may be adhered by an adhesive or the like, but may simply be brought into contact with each other. Note that the size of the receiving portion 20 a of the seal valve 20 may be reduced according to the outer dimension of the lower end of the standing leg portion 50 a in the rubber valve cover 51.
ゴム弁カバー50の半球状の頭部50bにおける外径寸法d1(図示省略)は、キャップ30のスリーブ部30cの内径寸法d2(図示省略)よりも小さく(d1<d2)して、ゴム弁カバー50に締付力が作用しないようにしてもよいし、d1≒d2またはd1>d2にしてもよい。 The outer diameter d1 (not shown) of the hemispherical head 50b of the rubber valve cover 50 is smaller than the inner diameter d2 (not shown) of the sleeve 30c of the cap 30 (d1 <d2), so that the rubber valve cover No tightening force may be applied to 50, or d1≈d2 or d1> d2.
また、ゴム弁カバー50の頭部50bは、スリーブ部30cの上端とほぼ同一の高さになるようにしてある。このとき、ゴム弁カバー50の頭部50bは、スリーブ部30cの上端よりも若干凹入させる方が、混注管1aへの注射器40の挿入接続時、または混注管1aからの注射器40の抜取り時などに、不用意に取扱者の手や他の機器がゴム弁カバー50の頭部50bに接触して汚染されることがないため、また、残留した血液や薬液がこぼれ落ちないため、望ましい。 Further, the head portion 50b of the rubber valve cover 50 is set to be almost the same height as the upper end of the sleeve portion 30c. At this time, the head portion 50b of the rubber valve cover 50 is slightly recessed from the upper end of the sleeve portion 30c when the syringe 40 is inserted into the mixed injection tube 1a or when the syringe 40 is removed from the mixed injection tube 1a. For example, the operator's hand and other equipment are not inadvertently contacted with the head 50b of the rubber valve cover 50 and contaminated, and the remaining blood and chemicals are not spilled off.
上記第2の実施形態の混注管1aにおけるキャップ30のスリーブ部30cの螺合片30dに、図2に示す注射器40のカラー部45の雌ねじ部46を螺合状態(ツイストロック)にすると、注射器40の口部44によって、図4(B)に示すように、ゴム弁カバー50が押圧変形されて、その貫通孔50cが開口すると共に、シール弁20も押圧変形されて、その弁孔20bが開口する。この開口状態の貫通孔50cおよび弁孔20bを通して、注射器40内の血液や薬液を混注管1a内の血液や薬液に混注することができる。また、必要に応じて、混注管1a内の血液や薬液を注射器40に抽出することもできる。 When the female threaded portion 46 of the collar portion 45 of the syringe 40 shown in FIG. 2 is screwed into the screwed piece 30d of the sleeve portion 30c of the cap 30 in the mixed injection tube 1a of the second embodiment, the syringe is placed. As shown in FIG. 4B, the rubber valve cover 50 is pressed and deformed by the opening 44 of the 40, the through hole 50c is opened, and the seal valve 20 is also pressed and deformed, so that the valve hole 20b is formed. Open. Through this through-hole 50c and the valve hole 20b in the open state, blood and chemical liquid in the syringe 40 can be mixed and injected into blood and chemical liquid in the mixed injection tube 1a. Moreover, the blood and the chemical | medical solution in the mixed injection tube 1a can also be extracted to the syringe 40 as needed.
注射器40のカラー部45の雌ねじ部46とスリーブ部30cの螺合片30dとの螺合状態を解除して注射器40を抜取ると、ゴム弁カバー50およびシール弁20は、それぞれの有する弾性復元力によって、図4(A)に示す元の形状に復帰すると共に、ゴム弁カバー50の貫通孔50cが縮小または閉止すると共に、シール弁20の弁孔20bが圧着密閉されて、血液や薬液の漏出を防止する。 When the threaded state of the female threaded portion 46 of the collar portion 45 of the syringe 40 and the threaded piece 30d of the sleeve portion 30c is released and the syringe 40 is removed, the rubber valve cover 50 and the seal valve 20 are elastically restored. 4A, the through hole 50c of the rubber valve cover 50 is contracted or closed, and the valve hole 20b of the seal valve 20 is pressure-tightly sealed, so that blood or a chemical solution is removed. Prevent leakage.
しかも、シール弁20の上にゴム弁カバー50が配置されているので、シール弁20の受部20aに血液や薬液が残留しても、残留した血液や薬液をゴム弁カバー50でカバーして、残留した血液や薬液が空気中の細菌などによって汚染されることが防止できる。また、万一、ゴム弁カバー50の頭部50bの上面に注射器40内または混注管1a内の血液や薬液が残留することがあっても、ゴム弁カバー50の頭部50bの上面がスリーブ部30cの上端とほぼ同一高さになっているので、アルコールを含ませたガーゼや綿などによって簡単に拭取ることができる。したがって、残留した血液や薬液が細菌に汚染されたり、乾燥固化したりすることに起因する、前述の問題を解消することができる。 Moreover, since the rubber valve cover 50 is disposed on the seal valve 20, even if blood or chemical liquid remains in the receiving portion 20a of the seal valve 20, the remaining blood or chemical liquid is covered with the rubber valve cover 50. It is possible to prevent the remaining blood and chemicals from being contaminated by bacteria in the air. Even if blood or chemicals in the syringe 40 or the mixed injection tube 1a may remain on the upper surface of the head portion 50b of the rubber valve cover 50, the upper surface of the head portion 50b of the rubber valve cover 50 remains on the sleeve portion. Since it is almost the same height as the upper end of 30c, it can be easily wiped with gauze or cotton containing alcohol. Therefore, it is possible to solve the above-mentioned problems caused by the remaining blood or chemical solution being contaminated by bacteria or being dried and solidified.
図5は、変形したゴム弁カバー51を有する第3の実施形態の混注管1bを示している。ゴム弁カバー51以外の部分は、図4に示す第2の実施形態の混注管1aと同様であるため、同一部分には同一参照符号を付して、その説明を省略する。この第3の実施形態の混注管1bにおけるゴム弁カバー51は、その立脚部51aを逆円錐形状にしたもので、このようにしても、図4(A)(B)に示すゴム弁カバー50を有する混注管1aと同様の機能が得られる。 FIG. 5 shows a mixed injection pipe 1b according to a third embodiment having a deformed rubber valve cover 51. FIG. Since the parts other than the rubber valve cover 51 are the same as those of the mixed injection pipe 1a of the second embodiment shown in FIG. 4, the same reference numerals are given to the same parts and the description thereof is omitted. The rubber valve cover 51 in the mixed injection pipe 1b of the third embodiment is such that the standing leg portion 51a has an inverted conical shape. Even in this case, the rubber valve cover 50 shown in FIGS. 4 (A) and 4 (B). A function similar to that of the mixed injection tube 1a having the above is obtained.
図6は、第4の実施形態の混注管1cを示す。この混注管1cは、キャップ31およびシール弁20の上面に配置されるゴム弁カバー52の形状が異なっている。すなわち、キャップ31は、分岐管部分13に係合する内周面に係合用凸部31aと、シール弁20の半球状外周面を押圧する凹円弧状部31bと、スリーブ部31cと、外周面上端に螺合片31dと、上端内周に鍔部31eとを有する。ゴム弁カバー52は、略楕円形状の立脚部52aと、半球状の頭部52bと、この頭部52bの中央部に形成された貫通孔52cと、頭部52bの周辺部に形成された平面部52dとを有する。そして、鍔部31eの下面を、ゴム弁カバー52の平面部52dとを対向させて、ゴム弁カバー52がスリーブ部31cから抜出さないようにしている。 FIG. 6 shows a mixed injection tube 1c according to the fourth embodiment. In the mixed injection pipe 1 c, the shapes of the rubber valve cover 52 arranged on the upper surface of the cap 31 and the seal valve 20 are different. That is, the cap 31 includes an engaging convex portion 31a on the inner peripheral surface that engages with the branch pipe portion 13, a concave arc-shaped portion 31b that presses the hemispherical outer peripheral surface of the seal valve 20, a sleeve portion 31c, and an outer peripheral surface. A threaded piece 31d is provided at the upper end, and a flange 31e is provided at the inner periphery of the upper end. The rubber valve cover 52 includes a substantially elliptical standing leg portion 52a, a hemispherical head portion 52b, a through hole 52c formed in the central portion of the head portion 52b, and a flat surface formed in the peripheral portion of the head portion 52b. Part 52d. The bottom surface of the flange portion 31e is opposed to the flat surface portion 52d of the rubber valve cover 52 so that the rubber valve cover 52 is not pulled out from the sleeve portion 31c.
この第4の実施形態の混注管1cにおいては、注射器40の抜取り時に、スリーブ部の鍔部31eによってゴム弁カバー52の平面部52dが阻止されて、スリーブ部31cからゴム弁カバー52の抜出しが確実に防止できるので、図4,図5に示す第2,第3の実施形態の混注管1a,1bのように、ゴム弁カバー51,52自体の弾性力およびスリーブ部31cの締付力によって抜出し防止を行う場合に比較して、ゴム弁カバー51,52の外径寸法とスリーブ部31cの内径寸法とのクリアランス設定が容易になる。なお、キャップ31の鍔部31eでゴム弁カバー52の平面部52dを押圧すれば、ゴム弁カバー52をシール弁20に対して押付け、シール弁20とゴム弁カバー52との接触部または接合部からの血液や薬液の漏れを確実に防止することができる。したがって、シール弁20とゴム弁カバー52とは必ずしも接着する必要はなく、単に接触させるのみでもよい。あるいは、キャップ31の鍔部31eとゴム弁カバー52の平面部52dとは、微小隙間で対向するようにしてもよい。 In the mixed injection tube 1c of the fourth embodiment, when the syringe 40 is pulled out, the flat portion 52d of the rubber valve cover 52 is blocked by the flange portion 31e of the sleeve portion, and the rubber valve cover 52 is pulled out from the sleeve portion 31c. Since it can be surely prevented, the elastic force of the rubber valve covers 51 and 52 itself and the tightening force of the sleeve portion 31c as in the mixed injection pipes 1a and 1b of the second and third embodiments shown in FIGS. As compared with the case where the removal prevention is performed, the clearance between the outer diameter of the rubber valve covers 51 and 52 and the inner diameter of the sleeve portion 31c can be easily set. If the flat portion 52d of the rubber valve cover 52 is pressed by the flange portion 31e of the cap 31, the rubber valve cover 52 is pressed against the seal valve 20, and the contact portion or joint portion between the seal valve 20 and the rubber valve cover 52 is pressed. Leakage of blood and chemicals from can be reliably prevented. Therefore, the seal valve 20 and the rubber valve cover 52 are not necessarily bonded, and may simply be brought into contact with each other. Alternatively, the flange portion 31e of the cap 31 and the flat surface portion 52d of the rubber valve cover 52 may face each other with a minute gap.
図7は第5の実施形態の混注管1dを示す。この混注管1dのキャップ32は、分岐管部分13との係合部の内周面に係合用の凸部32aと、シール弁25の半球状の外周面を押圧する凹円弧状部32bと、スリーブ部32cと、スリーブ部32cの外周面上端に螺合片32dと、上端内周部に鍔部32eと、この鍔部32eと内周面との間の凹円弧状部32fとを有する。また、シール弁25は、全体としては略半球状であるが、上面が平坦面25aに形成され、その中央部に弁孔25bが形成されている。さらに、ゴム弁カバー53は、逆円錘形状の立脚部53aと、半球状の頭部53bと、この頭部53bの中央部に形成された貫通孔53cと、前記立脚部53aの下端に形成された鍔部53dとを有する。そして、キャップ32を分岐管部分13に係合することによって、キャップ32の凹円弧状部32fで、ゴム弁カバー53の抜出しを防止している。 FIG. 7 shows a mixed injection tube 1d of the fifth embodiment. The cap 32 of the mixed injection pipe 1d includes an engaging convex portion 32a on the inner peripheral surface of the engaging portion with the branch pipe portion 13, and a concave arc-shaped portion 32b that presses the hemispherical outer peripheral surface of the seal valve 25; The sleeve portion 32c has a threaded piece 32d at the upper end of the outer peripheral surface of the sleeve portion 32c, a flange portion 32e at the inner peripheral portion of the upper end, and a concave arcuate portion 32f between the flange portion 32e and the inner peripheral surface. The seal valve 25 is generally hemispherical as a whole, but its upper surface is formed on a flat surface 25a, and a valve hole 25b is formed at the center thereof. Further, the rubber valve cover 53 is formed at an inverted-conical standing leg portion 53a, a hemispherical head portion 53b, a through hole 53c formed at the center of the head portion 53b, and a lower end of the standing leg portion 53a. And a flange portion 53d. By engaging the cap 32 with the branch pipe portion 13, the rubber valve cover 53 is prevented from being pulled out by the concave arc-shaped portion 32 f of the cap 32.
この第5の実施形態の混注管1dによっても、キャップ32の凹円弧状部32fで、前述の図6に示す混注管1cと同様に、ゴム弁カバー52の抜出しを防止することができるという機能が得られる。しかも、図6に示す混注管1cに比較して、ゴム弁カバー53の頭部53bの周辺部に平面部(52d)がないので、ゴム弁カバー53の形状を単純化でき、コスト低減ができる。また、シール弁25の平坦面25aと、ゴム弁カバー53の鍔部53dとが面同士で当接されるので、スリーブ部32cに注射器40の口部44を挿入してゴム弁カバー53およびシール弁25を押圧変形させる際に、ゴム弁カバー53とシール弁25との間に十分な液密性が得られる。さらに、シール弁25の半球状の頭部53bとキャップ30の凹円弧状部32fとが面接触しているので、ゴム弁カバー53の局部に大きな力が掛からない。 Also with the mixed injection tube 1d of the fifth embodiment, the concave arc-shaped portion 32f of the cap 32 can prevent the rubber valve cover 52 from being pulled out as in the mixed injection tube 1c shown in FIG. Is obtained. In addition, as compared with the mixed injection pipe 1c shown in FIG. 6, the rubber valve cover 53 can be simplified in shape and cost can be reduced because there is no flat portion (52d) around the head 53b of the rubber valve cover 53. . Further, since the flat surface 25a of the seal valve 25 and the flange portion 53d of the rubber valve cover 53 are in contact with each other, the mouth portion 44 of the syringe 40 is inserted into the sleeve portion 32c, and the rubber valve cover 53 and the seal. When the valve 25 is pressed and deformed, sufficient liquid tightness is obtained between the rubber valve cover 53 and the seal valve 25. Furthermore, since the hemispherical head portion 53b of the seal valve 25 and the concave arcuate portion 32f of the cap 30 are in surface contact, a large force is not applied to the local portion of the rubber valve cover 53.
図8は、第6の実施形態の混注管1eを示す。この混注管1eは、上面に受部20aを形成し、この受部20aに弁孔20bを形成した半球状のシール弁20の受部20a上に、ゴム弁カバー54が配置されている。また、キャップ31は、係合用の凸部31aと、シール弁20の半球状の外周面を押圧する凹円弧状部31bと、スリーブ部31cと、スリーブ部31cの外周面上端の螺合片31dと、上端内周に鍔部31eとを有する。さらに、ゴム弁カバー54は、逆円錐状の立脚部54aと、半球状の頭部54bと、この頭部54bに形成された貫通孔54cと、立脚部52aの下端外周に形成された鍔部54dとを有する。そして、シール弁20の受部20aに、ゴム弁カバー54の鍔部54dが嵌合されている。 FIG. 8 shows a mixed injection tube 1e of the sixth embodiment. The mixed injection pipe 1e has a receiving portion 20a formed on the upper surface, and a rubber valve cover 54 is disposed on the receiving portion 20a of the hemispherical seal valve 20 having a valve hole 20b formed in the receiving portion 20a. The cap 31 includes an engaging convex portion 31a, a concave arc-shaped portion 31b that presses the hemispherical outer peripheral surface of the seal valve 20, a sleeve portion 31c, and a threaded piece 31d at the upper end of the outer peripheral surface of the sleeve portion 31c. And a flange 31e on the inner periphery of the upper end. Further, the rubber valve cover 54 includes an inverted conical standing leg portion 54a, a hemispherical head portion 54b, a through hole 54c formed in the head portion 54b, and a flange portion formed on the outer periphery of the lower end of the standing leg portion 52a. 54d. The flange portion 54 d of the rubber valve cover 54 is fitted into the receiving portion 20 a of the seal valve 20.
この第6の実施形態の混注管1eにおいても、スリーブ部31の鍔部31eによって、図6,図7に示す第4,第5の実施形態の混注管1c,1dと同様に、ゴム弁カバー54がスリーブ部31cから脱出するのを防止することができる。 Also in the mixed injection pipe 1e of the sixth embodiment, the rubber valve cover is provided by the flange 31e of the sleeve portion 31 in the same manner as the mixed injection pipes 1c and 1d of the fourth and fifth embodiments shown in FIGS. 54 can be prevented from escaping from the sleeve portion 31c.
図9は第7の実施形態の混注管1fを示す。この混注管1fは、図6に示す第4の実施形態の混注管1cを改良したもので、キャップ33とゴム弁カバー55とが異なっている。すなわち、キャップ33は、係合用の凸部33aと、凹円弧状部33bと、スリーブ部33cと、螺合片33dと、上端内周に鍔部33eとを有し、ゴム弁カバー55は、その立脚部55aの高さ寸法を小さくして、全体としてほぼ球状に形成され、その頭部55bの中央部には、貫通孔55cが形成されており、頭部55bの周辺部に平面部55dが形成されている。 FIG. 9 shows a mixed injection tube 1f of the seventh embodiment. This mixed injection tube 1f is an improvement of the mixed injection tube 1c of the fourth embodiment shown in FIG. 6, and the cap 33 and the rubber valve cover 55 are different. That is, the cap 33 has an engaging convex portion 33a, a concave arc-shaped portion 33b, a sleeve portion 33c, a threaded piece 33d, and a flange portion 33e on the inner periphery of the upper end. The height of the standing leg portion 55a is reduced to form a substantially spherical shape as a whole. A through hole 55c is formed at the center of the head portion 55b, and a flat portion 55d is formed around the head portion 55b. Is formed.
そして、キャップ33の鍔部33eによって、図6〜図8に示す第4〜第6の実施形態の混注管1c〜1eと同様に、ゴム弁カバー55がスリーブ部33cから抜出すのを防止することができる。 Then, the rubber valve cover 55 is prevented from being pulled out from the sleeve portion 33c by the flange portion 33e of the cap 33, similarly to the mixed injection tubes 1c to 1e of the fourth to sixth embodiments shown in FIGS. be able to.
図10は第8の実施形態の混注管1gを示す。この混注管1gは、図9の混注管1fを変形したもので、キャップ34およびゴム弁カバー56の形状を変更している。すなわち、キャップ34は、係合用の凸部34aと、シール弁20の半球状の外周面を押圧する凹円弧状部34bと、スリーブ部34cと、螺合片34dと、上端内周に鍔部34eとを有する。また、ゴム弁カバー56は、立脚部56aを含む全体形状が扁平球状に形成されており、頭部56bの中央部に貫通孔56cが形成されている。このゴム弁カバー56の頭部56bの周辺部には、図9のゴム弁カバー55のような平面部55dは形成されていない。 FIG. 10 shows a mixed injection tube 1g of the eighth embodiment. This mixed injection tube 1g is a modification of the mixed injection tube 1f of FIG. 9, and the shapes of the cap 34 and the rubber valve cover 56 are changed. That is, the cap 34 includes an engaging convex portion 34a, a concave arc-shaped portion 34b that presses the hemispherical outer peripheral surface of the seal valve 20, a sleeve portion 34c, a screwing piece 34d, and a flange portion on the inner periphery of the upper end. 34e. The rubber valve cover 56 has a flat spherical shape as a whole including the standing leg portion 56a, and a through hole 56c is formed at the center of the head portion 56b. A flat portion 55d like the rubber valve cover 55 of FIG. 9 is not formed around the head portion 56b of the rubber valve cover 56.
この第8の実施形態の混注管1gによれば、キャップ34の鍔部34eにより、図9に示す第7の実施形態の混注管1fと同様に、ゴム弁カバー56がスリーブ部34cから抜出すことが防止できる。 According to the mixed injection tube 1g of the eighth embodiment, the rubber valve cover 56 is pulled out from the sleeve portion 34c by the flange portion 34e of the cap 34, similarly to the mixed injection tube 1f of the seventh embodiment shown in FIG. Can be prevented.
図11の(A)は第9の実施形態の混注管1hを示す。この混注管1hは、図4〜図10に示す第2〜第8の実施形態の混注管1a〜1gが、シール弁20,25と、ゴム弁カバー50〜56とを別々に製造し、これらを組合せて使用する構成のものであるのに対して、球状のシール弁に口部のスリーブ部挿入により押圧下降した頭部が、口部が抜取られたときに頭部の位置をスリーブ部内の所定位置に復元させるクッション部を一体に形成したシール弁60を用いるものである。 FIG. 11 (A) shows a mixed injection tube 1h according to the ninth embodiment. In the mixed injection pipe 1h, the mixed injection pipes 1a to 1g of the second to eighth embodiments shown in FIGS. 4 to 10 separately manufacture the seal valves 20 and 25 and the rubber valve covers 50 to 56. In contrast, the head that has been pushed down by inserting the sleeve portion of the mouth into the spherical seal valve, the position of the head in the sleeve when the mouth is removed. A seal valve 60 in which a cushion part to be restored to a predetermined position is integrally formed is used.
管本体10の分岐管部分14は、図4〜図10の実施形態の混注管1a〜1gに示す分岐管部分13と異なり、その内周面に係合用の凸部14aが設けられている。また、シール弁60は、略ラッパ状の位置復元可能なクッション部60aと、このクッション部60aに連続する略半球状の頭部60bと、この略半球状の頭部60bの上面に形成された注射器40の口部44の受部60cと、この受部60cの中央部に形成された貫通孔60dと、前記クッション部60aの下端の基部60eとを有する。また、キャップ35は、その外周面に係合用の凹部35aと、スリーブ部35bと、スリーブ部35bの上端外周の螺合片35cと、スリーブ部35bの上端内周の鍔部35dと、この鍔部35dと内周面とを結ぶ凹円弧状部35eとを有する。そして、シール弁60の頭部60bがスリーブ部35bの凹円弧状部35eによって締付力を受けて、弁孔60dが圧着密閉されている。また、シール弁60のクッション部60aの基部60eが、管本体10の鍔部10bとキャップ35の下端とによって挟持されている。 The branch pipe portion 14 of the pipe body 10 is different from the branch pipe portion 13 shown in the mixed injection pipes 1a to 1g in the embodiments of FIGS. 4 to 10, and an engagement convex portion 14a is provided on the inner peripheral surface thereof. The seal valve 60 is formed on a substantially trumpet-shaped position-recoverable cushion portion 60a, a substantially hemispherical head 60b continuous to the cushion portion 60a, and an upper surface of the substantially hemispherical head 60b. It has the receiving part 60c of the opening | mouth part 44 of the injection device 40, the through-hole 60d formed in the center part of this receiving part 60c, and the base 60e of the lower end of the said cushion part 60a. The cap 35 has an engaging recess 35a, a sleeve portion 35b, a threaded piece 35c on the outer periphery at the upper end of the sleeve portion 35, a flange portion 35d on the inner periphery at the upper end of the sleeve portion 35b, and the flange 35d. It has a concave arcuate part 35e connecting the part 35d and the inner peripheral surface. The head 60b of the seal valve 60 receives a tightening force by the concave arcuate portion 35e of the sleeve portion 35b, and the valve hole 60d is pressure-tightly sealed. Further, the base portion 60 e of the cushion portion 60 a of the seal valve 60 is sandwiched between the flange portion 10 b of the pipe body 10 and the lower end of the cap 35.
図11(B)は、この第9の実施形態の混注管1hに、注射器40を螺合(ツイストロック)した状態を示し、注射器40の口部44によって、シール弁60のクッション部60aが押し下げられると、頭部60bがキャップ35の円弧状部35eによる締付力から解放されると共に、頭部60bの押圧変形に伴って、図11(B)に示すように、シール弁60の弁孔60dが開口して、注射器40内の血液や薬液を、混注管1hを介して輸液回路の血液や薬液に混注できる。また、シール弁60の基部60eが、管本体10の鍔部10bとキャップ35の下端とによって挟持されているので、シール弁60の押圧変形時に、シール弁60のクッション部60aの下端が中心に寄ってクッション部60a内を閉塞することがない。 FIG. 11B shows a state where the syringe 40 is screwed (twist-locked) with the mixed injection tube 1h of the ninth embodiment, and the cushion portion 60a of the seal valve 60 is pushed down by the mouth portion 44 of the syringe 40. Then, the head 60b is released from the tightening force by the arc-shaped portion 35e of the cap 35, and as the head 60b is pressed and deformed, as shown in FIG. 60d opens and the blood and the chemical | medical solution in the syringe 40 can be mixedly injected into the blood and the chemical | medical solution of an infusion circuit via the mixed injection tube 1h. Further, since the base portion 60e of the seal valve 60 is sandwiched between the flange portion 10b of the pipe body 10 and the lower end of the cap 35, the lower end of the cushion portion 60a of the seal valve 60 is centered when the seal valve 60 is pressed and deformed. The cushion part 60a is not closed by closing.
この第9の実施形態の混注管1hによれば、シール弁60のクッション部60aによって、頭部60bの高さ位置が、スリーブ部35bの上端位置とほぼ一致しているので、図4〜図10に示す第2〜第8の実施形態の混注管1a〜1gと同様に、注射器40の口部44をスリーブ部35bから抜取った後のシール弁60の頭部60cに血液や薬液が滞留していても、アルコールを含ませたガーゼや綿などによって、簡単に拭取ることができる。しかも、シール弁とゴム弁カバーとを別々に製造し、これらのシール弁とゴム弁カバーとを組合わせて使用するものに比較して、混注管1hの製造、組立、保守などが容易になる。 According to the mixed injection tube 1h of the ninth embodiment, the height position of the head portion 60b substantially coincides with the upper end position of the sleeve portion 35b by the cushion portion 60a of the seal valve 60. Similarly to the mixed injection tubes 1a to 1g of the second to eighth embodiments shown in FIG. 10, blood and chemicals stay in the head 60c of the seal valve 60 after the mouth portion 44 of the syringe 40 is removed from the sleeve portion 35b. Even if it is done, it can be easily wiped off with gauze or cotton soaked in alcohol. Moreover, the manufacture, assembly, maintenance, etc. of the mixed injection tube 1h are facilitated as compared with the case where the seal valve and the rubber valve cover are separately manufactured and these seal valves and the rubber valve cover are used in combination. .
図12の(A)(B)は、第10の実施形態の混注管1iを示す。この混注管1iは、改良したキャップ36およびシール弁61を用いている。すなわち、キャップ36は、下端内周面に係合用の凸部36aと、スリーブ部36bと、スリーブ部36bの上端外周面に螺合片36cと、上端内周に鍔部36dと、鍔部36dと内面部との間に断面形状が凹円弧状部36eとを有する。さらに、シール弁61は、略逆円錐形状の立脚部61aと、この立脚部61aと連続する球状の頭部61bと、この頭部61bの上面の受部61cと、この受部61cの中央部に形成された弁孔61dと、前記立脚部61aの下端から外方に向かって水平状に延びる円盤状のクッション部61eとを有する。そして、キャップ36の凹円弧状部36eで、シール弁61の頭部61bを締付けて、常時は弁孔61dを圧着密閉すると共に、シール弁61のクッション部61eを、分岐管部分13の上端面とキャップ36とで挟持している。 FIGS. 12A and 12B show a mixed injection tube 1i of the tenth embodiment. This mixed injection pipe 1i uses an improved cap 36 and seal valve 61. That is, the cap 36 has an engaging convex portion 36a on the inner peripheral surface at the lower end, a sleeve portion 36b, a threaded piece 36c on the outer peripheral surface at the upper end of the sleeve portion 36b, a flange portion 36d on the inner peripheral surface at the upper end, and a flange portion 36d. And a concave arcuate portion 36e between the inner surface portion and the inner surface portion. Further, the seal valve 61 includes a substantially inverted conical standing leg portion 61a, a spherical head portion 61b continuous with the standing leg portion 61a, a receiving portion 61c on the upper surface of the head portion 61b, and a central portion of the receiving portion 61c. And a disc-shaped cushion portion 61e extending horizontally from the lower end of the standing leg portion 61a outward. The head portion 61b of the seal valve 61 is tightened with the concave arc-shaped portion 36e of the cap 36, and the valve hole 61d is normally crimped and sealed, and the cushion portion 61e of the seal valve 61 is connected to the upper end surface of the branch pipe portion 13. And the cap 36.
図12の(B)は、第10の実施形態の混注管1iに注射器40を螺合(ツイストロッ)した状態を示している。注射器40の口部44によりシール弁61が押圧されると、クッション部61eが押し下げられることによって、頭部62bがキャップ36の凹円弧状部36eによる締付力から解放されて、弁孔61dが開口して、注射器40内の血液や薬液を、混注管1iを介して輸液回路の血液や薬液に混注することができる。 FIG. 12B shows a state in which the syringe 40 is screwed (twisted) with the mixed injection tube 1i of the tenth embodiment. When the seal valve 61 is pressed by the mouth portion 44 of the syringe 40, the cushion portion 61e is pushed down, so that the head portion 62b is released from the tightening force by the concave arc-shaped portion 36e of the cap 36, and the valve hole 61d is formed. It opens and can mix blood and the chemical | medical solution in the syringe 40 into the blood and chemical | medical solution of an infusion circuit via the mixed injection pipe | tube 1i.
図13は、第11の実施形態の混注管1jを示す。この混注管1jは、図12に示す第10の実施形態の混注管1iを変形したもので、シール弁62の形状が異なっている。すなわち、シール弁62は、円筒状の立脚部62aと、この立脚部62aに連続する球状の頭部62bと、この頭部62bの中央部に形成された弁孔62cと、前記立脚部62aの下端から外方に向かって延びるクッション部62dと、このクッション部62dから分岐管部分13の内面に沿って立下がり、立脚部62aの下端に向かって延びる凹円弧状部62eとを有する。そして、キャップ36の円弧状部36eでシール弁62の球状の頭部62bを締付けて、頭部62bに設けた弁孔62cを圧着密閉すると共に、シール弁62の鍔部62dを分岐管部分13の上端面とキャップ36の下面とで挟持している。 FIG. 13 shows a mixed injection tube 1j of the eleventh embodiment. This mixed injection pipe 1j is a modification of the mixed injection pipe 1i of the tenth embodiment shown in FIG. 12, and the shape of the seal valve 62 is different. That is, the seal valve 62 includes a cylindrical standing leg part 62a, a spherical head part 62b continuous to the standing leg part 62a, a valve hole 62c formed in the center part of the head part 62b, and the standing leg part 62a. A cushion part 62d extending outward from the lower end and a concave arcuate part 62e falling from the cushion part 62d along the inner surface of the branch pipe portion 13 and extending toward the lower end of the standing leg part 62a. Then, the spherical head portion 62b of the seal valve 62 is tightened by the arc-shaped portion 36e of the cap 36, the valve hole 62c provided in the head portion 62b is crimped and sealed, and the flange portion 62d of the seal valve 62 is connected to the branch pipe portion 13. Is sandwiched between the upper end surface and the lower surface of the cap 36.
この第11の実施形態の混注管1jによれば、図12に示す第10の実施形態の混注管1iと同様の機能が得られるだけでなく、シール弁62の頭部62bが球形状であるため、注射器40の口部44で押圧した際に、頭部62bの変形が容易で、弁孔62cが確実に開口し、また、注射器40を抜取った際に、凹円弧状部62eの存在によって、クッション部62dの位置復元力も優れており、弁孔62cを確実に圧着密閉できる。さらにまた、頭部62bがキャップ36のスリーブ部36bの上端部と略同一高さであるため、頭部62bの上面に滞留した血液や薬液の拭取りも容易である。さらに、分岐管部分13の内面に沿って立下がる凹円弧状部62eによって、分岐管部分13とシール弁62とキャップ36とのシール性がより一層高くなる。 According to the mixed injection tube 1j of the eleventh embodiment, the same function as that of the mixed injection tube 1i of the tenth embodiment shown in FIG. 12 is obtained, and the head 62b of the seal valve 62 is spherical. Therefore, the head 62b is easily deformed when pressed by the mouth portion 44 of the syringe 40, the valve hole 62c is reliably opened, and the presence of the concave arc-shaped portion 62e when the syringe 40 is removed. Therefore, the position restoring force of the cushion part 62d is also excellent, and the valve hole 62c can be securely crimped and sealed. Furthermore, since the head portion 62b is substantially the same height as the upper end portion of the sleeve portion 36b of the cap 36, it is easy to wipe off the blood and chemicals accumulated on the upper surface of the head portion 62b. Furthermore, the concave arc-shaped portion 62e that falls along the inner surface of the branch pipe portion 13 further enhances the sealing performance of the branch pipe portion 13, the seal valve 62, and the cap 36.
図14は第12の実施形態の混注管1kを示す。この混注管1kは、シール弁63の上にゴム弁カバー57を配置したものである。すなわち、図12の実施形態に示すように、シール弁61のみを用いることが望ましいが、シール弁63の材質などによっては、立脚部を長く形成することができない場合がある。そのような場合には、本実施形態のように、シール弁63の上にゴム弁カバー57を配置することが有効である。 FIG. 14 shows a mixed injection tube 1k according to the twelfth embodiment. This mixed injection pipe 1k is obtained by arranging a rubber valve cover 57 on a seal valve 63. That is, as shown in the embodiment of FIG. 12, it is desirable to use only the seal valve 61, but depending on the material of the seal valve 63 and the like, there are cases where the standing leg portion cannot be formed long. In such a case, it is effective to arrange the rubber valve cover 57 on the seal valve 63 as in this embodiment.
キャップ37は、係合用凸部37aと、スリーブ部37bと、螺合片37cと、鍔部37dとを有する。シール弁63は、立脚部63aが略球状の頭部63bに含まれ、頭部63bの上面にリング部63cが形成され、このリング部63cの中央部に弁孔63dが形成されている。このシール弁63の上に配置されたゴム弁カバー57は、天板57aおよび底板57bを有する扁平円筒状に形成され、天板57aの中央部に貫通孔57cを有すると共に、底板57bに、シール弁63のリング部63cが嵌合する孔57dを有する。そして、このゴム弁カバー57の天板57aの高さ位置が、キャップ37のスリーブ部37bの上端位置にほぼ一致している。 The cap 37 includes an engaging convex portion 37a, a sleeve portion 37b, a screwing piece 37c, and a flange portion 37d. The seal valve 63 includes a standing leg portion 63a in a substantially spherical head portion 63b, a ring portion 63c is formed on the upper surface of the head portion 63b, and a valve hole 63d is formed in the center portion of the ring portion 63c. The rubber valve cover 57 disposed on the seal valve 63 is formed in a flat cylindrical shape having a top plate 57a and a bottom plate 57b. The rubber plate cover 57 has a through-hole 57c in the center of the top plate 57a and a seal on the bottom plate 57b. There is a hole 57d into which the ring portion 63c of the valve 63 is fitted. The height position of the top plate 57 a of the rubber valve cover 57 substantially coincides with the upper end position of the sleeve portion 37 b of the cap 37.
上記の第12の実施形態によれば、シール弁63の頭部63bに血液や薬液が滞留しても、その上に配置されたゴム弁カバ−57によってカバーされているので、滞留した血液や薬液が空気中の細菌によって汚染されることが防止できる。また、万一、ゴム弁カバ−57の上に血液や薬液が滞留しても、ゴム弁カバー57の天板57aの高さ位置が、キャップ37のスリーブ部の上端位置にほぼ一致しているので、滞留した血液や薬液を簡単に拭取ることができる。 According to the above twelfth embodiment, even if blood or a chemical solution stays in the head portion 63b of the seal valve 63, it is covered by the rubber valve cover 57 disposed on the head or the liquid 63. The chemical solution can be prevented from being contaminated by airborne bacteria. In the unlikely event that blood or chemical liquid stays on the rubber valve cover 57, the height position of the top plate 57a of the rubber valve cover 57 substantially coincides with the upper end position of the sleeve portion of the cap 37. Therefore, it is possible to easily wipe off the staying blood and chemicals.
図15は第13実施形態の混注管1mを示す。この混注管1mは、管本体10の鍔部10bにシール弁64を載置し、キャップ38を管本体10の分岐管部分13に嵌め込んだものである。分岐管部分13の外周面上端には係合用の突部13aが形成されており、キャップ38は、下端内周面の係合用の凸部38aと、スリーブ部38bと、スリーブ部38bの上端外周面に螺合片38cと、上端内周に鍔部38dと、鍔部38dの内方端とスリーブ部38bの内面部との間に形成された断面形状が凹円弧状部38eとを有する。さらに、シール弁64は、下方に向かってラッパ状に拡開しているクッション部64aと、このクッション部64aに連続する円筒部64bと、この円筒部64bに連続する半球状の頭部64cと、この頭部64cに形成されたリング部64dと、このリング部64dの中央部に形成された弁孔64eとを有する。 FIG. 15 shows a mixed injection tube 1m according to the thirteenth embodiment. This mixed injection tube 1 m is obtained by placing a seal valve 64 on the flange 10 b of the tube body 10 and fitting a cap 38 into the branch tube portion 13 of the tube body 10. An engaging protrusion 13a is formed on the upper end of the outer peripheral surface of the branch pipe portion 13, and the cap 38 has an engaging convex portion 38a on the inner peripheral surface of the lower end, a sleeve portion 38b, and an upper end outer periphery of the sleeve portion 38b. A threaded piece 38c is formed on the surface, a flange portion 38d is formed on the inner periphery of the upper end, and a cross-sectional shape formed between the inner end of the flange portion 38d and the inner surface portion of the sleeve portion 38b is a concave arc-shaped portion 38e. Further, the seal valve 64 includes a cushion portion 64a that expands downward in a trumpet shape, a cylindrical portion 64b that continues to the cushion portion 64a, and a hemispherical head portion 64c that continues to the cylindrical portion 64b. The ring portion 64d is formed in the head portion 64c, and the valve hole 64e is formed in the center portion of the ring portion 64d.
上記第13実施形態の混注管1mは、クッション部64aのクッション作用によって、常時はシール弁64を上方に押し上げており、その半球状の頭部64cがキャップ38の凹円弧状部38eに押圧され、凹円弧状部38eによる頭部64cの締付力で、弁孔64eは圧着密閉状態になっている。また、キャップ38のスリーブ部38b内に注射器40の口部44を挿入し、カラー部45の雌ねじ部46をキャップ38の螺合片38cに螺合すると、シール弁64のクッション部64aがその弾性力に抗して押し下げられて、シール弁64の頭部64cがキャップ38の凹円弧状部38eによる締付力から解放される結果、シール弁64の弁孔64eは開口する。 In the mixed injection tube 1m of the thirteenth embodiment, the seal valve 64 is normally pushed upward by the cushioning action of the cushion portion 64a, and the hemispherical head portion 64c is pressed by the concave arc-shaped portion 38e of the cap 38. Due to the tightening force of the head 64c by the concave arcuate portion 38e, the valve hole 64e is in a pressure sealed state. Further, when the mouth portion 44 of the syringe 40 is inserted into the sleeve portion 38b of the cap 38 and the female screw portion 46 of the collar portion 45 is screwed into the screwing piece 38c of the cap 38, the cushion portion 64a of the seal valve 64 is elastically elastic. As a result of being pushed down against the force and releasing the head 64c of the seal valve 64 from the tightening force by the concave arcuate portion 38e of the cap 38, the valve hole 64e of the seal valve 64 opens.
図16(A)は第14実施形態の混注管1nを示す。この混注管1nは、シール弁65を混本体10の鍔部10bに載置し、キャップ30を管本体10の分岐管部分13に嵌め込んだものである。キャップ30は、図1に示すキャップ30とほぼ同様であるので、対応部分には同一符号を付してその説明を省略する。シール弁65は、図16(A)(B)に示すように、図15のクッション部64aよりも大きい拡開角度でアーチ型状に拡開しているクッション部65aと、このクッション部65aに連続する円筒部65bと、この円筒部65bに連続する頭部65cとを有し、この頭部65cの上面はアーチ型凹面形状65dに形成され、その中央部に断面形状がV字状の凹溝65eが形成され、この凹溝65eの中心部に弁孔65fが形成されている。 FIG. 16A shows a mixed injection tube 1n according to the fourteenth embodiment. In this mixed injection tube 1n, the seal valve 65 is placed on the flange portion 10b of the mixed body 10, and the cap 30 is fitted into the branch tube portion 13 of the tube body 10. Since the cap 30 is substantially the same as the cap 30 shown in FIG. 1, the corresponding parts are denoted by the same reference numerals, and the description thereof is omitted. As shown in FIGS. 16 (A) and 16 (B), the seal valve 65 has a cushion portion 65a that expands in an arch shape with a larger opening angle than the cushion portion 64a in FIG. 15, and the cushion portion 65a. It has a continuous cylindrical portion 65b and a head portion 65c continuous to the cylindrical portion 65b. The upper surface of the head portion 65c is formed into an arch-shaped concave shape 65d, and a concave portion having a V-shaped cross section at the center. A groove 65e is formed, and a valve hole 65f is formed at the center of the concave groove 65e.
この第14実施形態の混注管1nは、管本体10の鍔部10bにシール弁65のクッション部65aを載置し、キャップ30を被せて、その係合用の凸部30aを分岐管部分13の係合用の凸部13aに係合すると、常時はシール弁65のクッション部65aの弾性力によってシール弁65が持ち上げられ、その頭部65cがキャップ30の凹円弧状部30fに押圧されて、凹円弧状部30fによる頭部65cの締付力で、弁孔65fが圧着密閉状態になる。また、キャップ30のスリーブ部30c内に注射器40の口部44を挿入し、カラー部45の雌ねじ部46をキャップ30の螺合片30dに螺合すると、口部44でシール弁65がクッション部65aの弾性力に抗して押し下げられ、頭部65cがキャップ30の凹円弧状部30fによる締付力から解放されて、弁孔65fが開口する。 In the mixed injection tube 1n according to the fourteenth embodiment, the cushion portion 65a of the seal valve 65 is placed on the flange portion 10b of the tube body 10, the cap 30 is put on, and the convex portion 30a for engagement is formed on the branch tube portion 13. When engaged with the engaging convex portion 13a, the sealing valve 65 is normally lifted by the elastic force of the cushion portion 65a of the sealing valve 65, and its head portion 65c is pressed against the concave arc-shaped portion 30f of the cap 30 to form a concave portion. Due to the tightening force of the head portion 65c by the arc-shaped portion 30f, the valve hole 65f is brought into a pressure-tight state. Further, when the mouth portion 44 of the syringe 40 is inserted into the sleeve portion 30 c of the cap 30 and the female screw portion 46 of the collar portion 45 is screwed into the screwing piece 30 d of the cap 30, the seal valve 65 is cushioned at the mouth portion 44. It is pushed down against the elastic force of 65a, the head 65c is released from the tightening force by the concave arcuate portion 30f of the cap 30, and the valve hole 65f is opened.
ここで、シール弁65の頭部65cの上面にはアーチ型凹面形状65dに形成され、その中央心部に断面形状がV字状の凹溝65eが形成され、この凹溝65eの中心部に弁孔65fが形成されているので、図15におけるシール弁64に比較して、常時はキャップ30の凹円弧状部30fの締付力により弁孔65fが容易に圧着密閉状態になる。また、注射器40の口部44をキャップ30のスリーブ部30c内に挿入すると、シール弁65が変形されて弁孔65fが容易に開口する。さらに、頭部65cの上に血液や輸液が残留した場合、残留した血液や輸液がアーチ型凹面形状65dによって中央部に集まり易いので、拭取り作業が容易になる。 Here, an arch-shaped concave shape 65d is formed on the upper surface of the head 65c of the seal valve 65, and a concave groove 65e having a V-shaped cross-section is formed at the center of the central portion of the concave groove 65e. Since the valve hole 65f is formed, the valve hole 65f is always easily crimped and sealed by the tightening force of the concave arcuate portion 30f of the cap 30 as compared with the seal valve 64 in FIG. Further, when the mouth portion 44 of the syringe 40 is inserted into the sleeve portion 30c of the cap 30, the seal valve 65 is deformed and the valve hole 65f is easily opened. Further, when blood or infusion remains on the head 65c, the remaining blood or infusion tends to collect in the center by the arch-shaped concave surface shape 65d, so that the wiping operation is facilitated.
図17は第15実施形態の混注管1pを示す。この混注管1pは、半球状のシール弁21と有天円筒状のゴム弁カバー58を併用したもので、シール弁21は、図17(B)に示すように、図3(A)に示すシール弁21とほぼ同様であるため、対応部分には同一符号を付してその説明を省略する。また、キャップ32は、図7に示すキャップ32と同様であるため、同一部分には同一符号を付してその説明を省略する。ゴム弁カバー58は、これまでにない新しい形状で、図17(C)に示すように、円筒状の立脚部58aと、この立脚部58aに連続する天井部58bと、この天井部58bの中央部に形成された貫通孔58cと、天井部58bの肩部に形成された平面部58dと、立脚部58aの下端内周に形成された鍔部58eとを有する。なお、天井部58bは、上面58fおよび下面58gをアーチ型凹面形状に形成して、天井部58bが容易に変形するようにしている。 FIG. 17 shows a mixed injection tube 1p according to the fifteenth embodiment. This mixed injection pipe 1p is a combination of a hemispherical seal valve 21 and a celestial cylindrical rubber valve cover 58. The seal valve 21 is shown in FIG. 3 (A) as shown in FIG. 17 (B). Since it is almost the same as the seal valve 21, the same reference numerals are given to the corresponding parts, and the description thereof is omitted. Moreover, since the cap 32 is the same as the cap 32 shown in FIG. 7, the same code | symbol is attached | subjected to the same part and the description is abbreviate | omitted. The rubber valve cover 58 has an unprecedented new shape, and as shown in FIG. 17C, a cylindrical standing leg 58a, a ceiling 58b continuous to the standing leg 58a, and the center of the ceiling 58b. A through hole 58c formed in the portion, a flat portion 58d formed in the shoulder portion of the ceiling portion 58b, and a flange portion 58e formed in the inner periphery of the lower end of the standing leg portion 58a. The ceiling portion 58b is formed such that the upper surface 58f and the lower surface 58g are formed in an arched concave shape so that the ceiling portion 58b is easily deformed.
上記の第15実施形態の混注管1pは、管本体10の鍔部10bにシール弁21を載置し、このシール弁21の上にゴム弁カバー58を載置して、上方からキャップ31を被せて管本体10の分岐管部分13に嵌め込んだものである。常時はキャップ32の凹円弧状部32bによるシール弁21の締付力で、弁孔21bが圧着密閉状態になっている。キャップ32のスリーブ部32c内に注射器40の口部44を挿入し、カラー部45の雌ねじ部46をキャップ32の螺合片32dに螺合すると、ゴム弁カバー58およびシール弁21が口部44によって押圧変形され、シール弁21の弁孔21bが開口して、ゴム弁カバー58の貫通孔58cおよびシール弁65の弁孔21bを介して、注射器40の血液や輸液を混注管1pの輸液に混注することができる。なお、キャップ32のスリーブ部32cの内周面と、ゴム弁カバー58の円筒部58aの外周面との間には、図示するように、若干隙間を設けておく方が、ゴム弁カバー58の変形が容易になる。 In the mixed injection pipe 1p of the fifteenth embodiment, the seal valve 21 is placed on the flange 10b of the pipe body 10, the rubber valve cover 58 is placed on the seal valve 21, and the cap 31 is placed from above. It is fitted into the branch pipe portion 13 of the pipe body 10. Normally, the valve hole 21b is in a pressure-tight sealed state by the tightening force of the seal valve 21 by the concave arc-shaped portion 32b of the cap 32. When the mouth portion 44 of the syringe 40 is inserted into the sleeve portion 32 c of the cap 32 and the female screw portion 46 of the collar portion 45 is screwed into the screwing piece 32 d of the cap 32, the rubber valve cover 58 and the seal valve 21 are brought into the mouth portion 44. And the valve hole 21b of the seal valve 21 is opened, and the blood and the infusion solution of the syringe 40 are converted into the infusion solution of the mixed injection tube 1p through the through hole 58c of the rubber valve cover 58 and the valve hole 21b of the seal valve 65. Can be mixed. It should be noted that a slight gap is provided between the inner peripheral surface of the sleeve portion 32c of the cap 32 and the outer peripheral surface of the cylindrical portion 58a of the rubber valve cover 58, as shown in the figure. Deformation is easy.
図18は第16実施形態の混注管1qを示す。この混注管1qは、半球状のシール弁21と、有天円筒状のゴム弁カバー59とを併用したものである。シール弁21およびキャップ32は、図17のシール弁21およびキャップ32と同一であるので、同一部分にはそれぞれ同一符号を付してその説明を省略する。ゴム弁カバー59はこれまでにない新しい形態を有する。このゴム弁カバー59は、図18(B)に示すように、略円筒状部材59aと、その上に被せられたキャップ状部材59bとを組み合わせて有天円筒状にしたものである。前記略円筒状部材59aは、内周面上端部に凸円弧状面59cを有し、外周面下端に鍔部59dを有する。また、キャップ状部材59bは、その天井部59eの上面59fが凹面型形状に形成されており、下面が平面状に形成されている。この天井部59eの中心部に貫通孔59gが形成され、上面肩部に段部59hが形成されている。 FIG. 18 shows a mixed injection tube 1q according to the sixteenth embodiment. This mixed injection tube 1q is a combination of a hemispherical seal valve 21 and a cylindrical rubber valve cover 59. Since the seal valve 21 and the cap 32 are the same as the seal valve 21 and the cap 32 of FIG. 17, the same parts are denoted by the same reference numerals and the description thereof is omitted. The rubber valve cover 59 has an unprecedented new form. As shown in FIG. 18B, the rubber valve cover 59 is formed by combining a substantially cylindrical member 59a and a cap-like member 59b placed thereon to form a dome-like cylinder. The substantially cylindrical member 59a has a convex arcuate surface 59c at the upper end of the inner peripheral surface and a flange 59d at the lower end of the outer peripheral surface. Further, the cap-like member 59b has an upper surface 59f of the ceiling portion 59e formed in a concave shape and a lower surface formed in a flat shape. A through hole 59g is formed at the center of the ceiling portion 59e, and a stepped portion 59h is formed at the upper shoulder.
上記の第16実施形態の混注管1qは、管本体10の鍔部10bにシール弁21を載置し、このシール弁21の上にゴム弁カバー59を載置して、上方からキャップ32を被せて管本体10の分岐管部分13に嵌め込んだものである。常時はキャップ32の凹円弧状部32bによる締付力で、シール弁21の弁孔21bが圧着密閉状態になっている。キャップ32のスリーブ部32c内に注射器40の口部44を挿入し、カラー部45の雌ねじ部46をキャップ32の螺合片32dに螺合すると、ゴム弁カバー59およびシール弁21が口部44によって押圧変形され、シール弁21の弁孔21bが開口して、ゴム弁カバー58の貫通孔59gおよびシール弁65の弁孔21bを介して、注射器40の血液や輸液を混注管1qの輸液に混注することができる。 In the mixed injection pipe 1q of the sixteenth embodiment, the seal valve 21 is placed on the flange 10b of the pipe body 10, the rubber valve cover 59 is placed on the seal valve 21, and the cap 32 is placed from above. It is fitted into the branch pipe portion 13 of the pipe body 10. Normally, the valve hole 21b of the seal valve 21 is in a pressure-tight sealed state by the tightening force of the concave arcuate portion 32b of the cap 32. When the mouth part 44 of the syringe 40 is inserted into the sleeve part 32 c of the cap 32 and the female thread part 46 of the collar part 45 is screwed into the screwing piece 32 d of the cap 32, the rubber valve cover 59 and the seal valve 21 are brought into the mouth part 44. And the valve hole 21b of the seal valve 21 is opened, and the blood and infusion of the syringe 40 are transferred to the infusion of the mixed injection tube 1q through the through hole 59g of the rubber valve cover 58 and the valve hole 21b of the seal valve 65. Can be mixed.
ここで、略円筒状部材59aは、これまでに述べたゴム弁カバーに比較して、血液や輸液の流路の断面積を小さくして、この流路内に滞留する血液や輸液の滞留量を少なくできる。また、ゴム弁カバー59のキャップ状部材59bにおける上面肩部の段部59hが、キャップ32の鍔部32eの下面に当接して、ゴム弁カバー59の抜け出しを防止している。 Here, the substantially cylindrical member 59a has a smaller cross-sectional area of the blood or infusion flow channel than the rubber valve cover described so far, and the retention amount of the blood or infusion remaining in the flow channel. Can be reduced. Further, the stepped portion 59h of the upper shoulder portion of the cap-shaped member 59b of the rubber valve cover 59 is in contact with the lower surface of the flange portion 32e of the cap 32 to prevent the rubber valve cover 59 from coming off.
図19(A)(B)は、第17実施形態の混注管1rを示す。この混注管1rは、管本体10の分岐管部分にキャップを用いることなく、略円筒状のシール弁23を装着し得るようにしたものである。この混注管1rの分岐管部分、すなわちスリーブ部15は管本体10と一体に形成されており、図20(A)(B)に示すように、その内周面上部に断面形状がV字状などの係合用の凹部15aが形成され、この凹部15aの下方位置に段部15bが形成され、さらに、外周面上端部に螺合片15cが形成されている。また、シール弁23は、略円筒部23aと、この略円筒部23aに連続する天井部23bとを有し、天井部23bの上面23cはアーチ型凹面形状に形成され、下面23dはアーチ型凸面形状に形成されており、天井部23bには断面形状がV字状の凹溝23eが形成され、この凹溝23eの中央部に弁孔23fが形成されている。また、天井部23bの上面肩部には平面部23gが形成されている。さらに、シール弁23の上から、スリーブ部15内に、外周面に係合用凸部16aを有するリング状固定具16が挿入されて、その係合用の凸部16aをスリーブ部15の係合用凹部15aに嵌め込むことによって、シール弁23を着脱自在に装着している。 FIGS. 19A and 19B show a mixed injection tube 1r of the seventeenth embodiment. The mixed injection pipe 1r is configured such that a substantially cylindrical seal valve 23 can be attached to the branch pipe portion of the pipe body 10 without using a cap. The branch pipe portion of the mixed injection pipe 1r, that is, the sleeve portion 15 is formed integrally with the pipe body 10, and as shown in FIGS. 20A and 20B, the cross-sectional shape is V-shaped at the upper part of the inner peripheral surface thereof. A recess 15a for engagement is formed, a step portion 15b is formed at a position below the recess 15a, and a screwing piece 15c is formed at the upper end of the outer peripheral surface. Further, the seal valve 23 has a substantially cylindrical portion 23a and a ceiling portion 23b continuous with the substantially cylindrical portion 23a. The upper surface 23c of the ceiling portion 23b is formed in an arched concave shape, and the lower surface 23d is an arched convex surface. A concave groove 23e having a V-shaped cross section is formed in the ceiling portion 23b, and a valve hole 23f is formed in the central portion of the concave groove 23e. Further, a planar portion 23g is formed on the upper shoulder portion of the ceiling portion 23b. Further, the ring-shaped fixture 16 having the engaging convex portion 16 a on the outer peripheral surface is inserted into the sleeve portion 15 from above the seal valve 23, and the engaging convex portion 16 a is inserted into the engaging concave portion of the sleeve portion 15. The seal valve 23 is detachably mounted by being fitted into 15a.
この混注管1rは、スリーブ部15内にシール弁23を挿入して、略円筒部23aの下端を管本体10の段部10に載置し、その上からリング状固定具16を嵌め込むので、スリーブ部15の内面によって、あるいは、さらにリング状固定具16によって、シール弁23が圧縮力を受けて弁孔23fが圧着密閉状態になる。このとき、シール弁23の天井部23bの下面23dをアーチ型凸部形状に形成しているので、混注管10の輸液の内圧に対して、天井部23bの下面23dの弁孔23fが閉じられるような応力が作用するので、内圧によって輸液が漏れることが防止される。また、スリーブ部15内に注射器40の口部44を挿入すると、シール弁23が押圧変形されて弁孔23fが開口する。このとき、天井部23bの上面23cをアーチ型凹部形状に形成すると共に、V字状の凹溝23eを形成し、この凹溝23e内に弁孔23fを形成しているので、注射器40の口部44によってシール弁23が容易に押圧変形されて、弁孔23fが確実に開口する。さらに、スリーブ部15から注射器40の口部44を抜取ると、天井部23bの下面23dのアーチ型凸部形状によって、シール弁23が元の形状に確実に復元し、弁孔23fが再び圧着密閉状態になる。 In this mixed injection pipe 1r, the seal valve 23 is inserted into the sleeve part 15, the lower end of the substantially cylindrical part 23a is placed on the step part 10 of the pipe body 10, and the ring-shaped fixture 16 is fitted from above. The seal valve 23 receives a compressive force by the inner surface of the sleeve portion 15 or by the ring-shaped fixture 16, and the valve hole 23f is brought into a pressure-tight sealed state. At this time, since the lower surface 23d of the ceiling portion 23b of the seal valve 23 is formed in an arch-shaped convex shape, the valve hole 23f of the lower surface 23d of the ceiling portion 23b is closed against the internal pressure of the infusion of the mixed injection tube 10. Since such stress acts, the infusion is prevented from leaking due to the internal pressure. Further, when the mouth portion 44 of the syringe 40 is inserted into the sleeve portion 15, the seal valve 23 is pressed and deformed to open the valve hole 23f. At this time, the upper surface 23c of the ceiling portion 23b is formed in an arch-shaped concave shape, and a V-shaped concave groove 23e is formed, and a valve hole 23f is formed in the concave groove 23e. The seal valve 23 is easily pressed and deformed by the portion 44, and the valve hole 23f is reliably opened. Further, when the mouth portion 44 of the syringe 40 is removed from the sleeve portion 15, the seal valve 23 is reliably restored to the original shape by the arch-shaped convex shape of the lower surface 23d of the ceiling portion 23b, and the valve hole 23f is crimped again. Sealed.
この混注管1rは、リング状固定具16によってシール弁23を着脱自在に装着したので、シール弁23のスリーブ部15内への最初の装着作業や、シール弁23が摩耗や損傷した場合の交換作業を容易に実施することができる。また、リング状固定具16は、上下対称形状を有するので、スリーブ部15内に挿入する際に、その上下方向を判別しなくてすむ。しかも、これまで述べた実施形態のように、分岐管部分13,14にキャップ30〜37を装着するものに比較して、注射器接続ポート部分の構成が簡単になり、外形寸法を小さく、かつ、すっきりした外観にできる。 Since the mixed injection pipe 1r is detachably mounted with the seal valve 23 by the ring-shaped fixture 16, the first mounting operation of the seal valve 23 into the sleeve portion 15 or replacement when the seal valve 23 is worn or damaged. Work can be carried out easily. Further, since the ring-shaped fixture 16 has a vertically symmetrical shape, when inserted into the sleeve portion 15, it is not necessary to determine the vertical direction. In addition, as in the embodiment described so far, the structure of the syringe connection port portion becomes simpler than that in which the caps 30 to 37 are attached to the branch tube portions 13 and 14, the external dimensions are small, and A clean appearance is possible.
なお、スリーブ部15内にリング状固定具16を挿入することによって、シール弁23の上面23cがスリーブ部15の上端よりも若干低くなるが、このような段差が生じても、シール弁23の上面23cに残留する血液や輸液の拭取り作業には殆ど支障がないばかりか、却って段差によりリング状固定具16が注射器40の口部44の挿入時にガイドとなって、口部44のスリーブ部15内への挿入作業が容易、かつ、安定して行える利点がある。 By inserting the ring-shaped fixture 16 into the sleeve portion 15, the upper surface 23 c of the seal valve 23 is slightly lower than the upper end of the sleeve portion 15. The wiping operation of the blood and the infusion remaining on the upper surface 23c is hardly hindered. On the other hand, the ring-shaped fixture 16 becomes a guide when the mouth portion 44 of the syringe 40 is inserted due to the step, and the sleeve portion of the mouth portion 44 There is an advantage that the inserting operation into the tube 15 can be performed easily and stably.
また、シール弁23の略円筒部23aの肉厚が、下方に行くほど厚肉状態に形成されているので、円筒部を同一の肉厚にした場合に比較して、円筒部の下端に鍔部を形成する必要がないのみならず、シール弁23の血液や輸液の流路の断面積が小さくできることによって、シール弁23内に残留する血液や輸液量を少なくすることができる。ただし、円筒部の下端に鍔部を形成してもよい。 Further, since the thickness of the substantially cylindrical portion 23a of the seal valve 23 is formed so as to go downward, the thickness of the cylindrical portion is lower than that of the cylindrical portion as compared with the case where the cylindrical portion has the same thickness. It is not necessary to form a portion, and the cross-sectional area of the flow path of blood and infusion fluid of the seal valve 23 can be reduced, so that the amount of blood and infusion remaining in the seal valve 23 can be reduced. However, you may form a collar part in the lower end of a cylindrical part.
なお、これまで述べたシール弁20〜23やシール弁61〜65において、その上面および/または下面を、アーチ型凹部形状にすることによって、弁孔20b,25b,23fや60d,61d,62c,63d,64e,65fの近傍でより大きな圧縮応力が作用するため、弁孔20b,25b,23fや60d,61d,62c,63d,64e,65fが確実に圧着密閉される優れた作用を有するが、本発明はこれに限定されるものではなく、図示は省略するけれども、例えば、上面および下面とも平面状、または、上面および下面ともアーチ型凸部形状にしてもよい。また、上面が平面状で下面がアーチ型凹部形状もしくはアーチ型凸部形状、または、下面が平面状で上面がアーチ型凹部形状もしくはアーチ型凸部形状にしてもよい。さらには、上面がアーチ型凹部形状で下面が平面状もしくはアーチ型凸部形状や、上面がアーチ型凸部形状で下面が平面状もしくはアーチ型凹部形状に形成してもよい。 In addition, in the sealing valves 20 to 23 and the sealing valves 61 to 65 described so far, the valve holes 20b, 25b, 23f, 60d, 61d, 62c, Since a larger compressive stress acts in the vicinity of 63d, 64e, and 65f, the valve holes 20b, 25b, and 23f, and 60d, 61d, 62c, 63d, 64e, and 65f have an excellent effect of being securely crimped and sealed. The present invention is not limited to this, and although not shown in the drawings, for example, both the upper surface and the lower surface may be planar, or both the upper surface and the lower surface may have an arched convex shape. Alternatively, the upper surface may be planar and the lower surface may be an arch-shaped concave shape or arch-shaped convex shape, or the lower surface may be planar and the upper surface may be an arch-shaped concave shape or arch-shaped convex shape. Furthermore, the upper surface may be formed into an arch-shaped concave shape and the lower surface may be formed into a flat shape or an arch-shaped convex shape, or the upper surface may be formed into an arch-shaped convex shape and the lower surface may be formed into a flat shape or an arch-shaped concave shape.
また、ゴム弁カバー50〜59の貫通孔50c〜58c,59gは、シール弁やシール弁の弁孔のように混注管の内圧による血液や輸液の漏れを防止するものではないので、シール弁の弁孔のように圧着密閉を必要とするものではないが、例えば、上面を凹面、凸面または平面形状のいずれかを選択し、下面を凹面、凸面または平面形状のいずれかを選択して、断面形状を決定することができる。 Further, the through holes 50c to 58c and 59g of the rubber valve covers 50 to 59 do not prevent leakage of blood or infusion due to the internal pressure of the mixed injection pipe unlike the seal valve and the valve hole of the seal valve. Although it does not require crimping and sealing like a valve hole, for example, select either concave, convex or planar shape for the upper surface and select either concave, convex or planar shape for the lower surface, The shape can be determined.
以上、本発明の複数の実施形態例を説明してきたが、本発明は、これらの実施形態例にのみ制約されるものではなく、特許請求の範囲に記載してある事項の意味と範囲内の構成をもつ実施形態も本発明の範囲内に含まれることを意図している。例えば、各実施形態において、分岐管部分とスリーブ部とを凸部同士の嵌合によって係合する場合について説明したが、分岐管部分およびスリーブ部のいずれか一方に雄ねじ部を形成すると共に、他方に雌ねじ部を形成して、これらの雄ねじ部と雌ねじ部とを螺合することによって係合するようにしてもよい。 Although a plurality of exemplary embodiments of the present invention have been described above, the present invention is not limited only to these exemplary embodiments, and is within the meaning and scope of the matters described in the claims. Embodiments with configurations are intended to be included within the scope of the present invention. For example, in each embodiment, the case where the branch pipe portion and the sleeve portion are engaged by fitting the convex portions is described. However, the male screw portion is formed in one of the branch pipe portion and the sleeve portion, and the other An internal thread portion may be formed on the external thread portion, and the external thread portion and the internal thread portion may be screwed together to engage with each other.
また、上記各実施形態において説明した、管本体,キャップ,シール弁,ゴム弁カバーにおける個々の構成を、選択的に組合せるようにしてもよい。さらに、キャップの鍔部の内面からスリーブ部内面までを連絡する断面形状を凹円弧状部に代えて、テーパ面にしてもよい。 Moreover, you may make it selectively combine each structure in a pipe | tube main body, a cap, a seal valve, and a rubber valve cover demonstrated in each said embodiment. Furthermore, the cross-sectional shape that connects the inner surface of the collar portion of the cap to the inner surface of the sleeve portion may be a tapered surface instead of the concave arc-shaped portion.
また、図示は省略するが、シール弁を円盤状にすることもできる。ただし、この場合は、円盤状シール弁のスリーブ部内への取付位置を、注射器の口部によって押圧変形が可能な高さ位置に装着する必要がある。この円盤状シール弁においても、前記シール弁やゴム弁カバーで述べたと同様に、その上面および下面を、平面状、アーチ型凹部形状、アーチ型凸部形状の各種の組み合わせで構成することができる。 Although not shown, the seal valve can be a disk. However, in this case, it is necessary to mount the mounting position of the disc-shaped seal valve in the sleeve portion at a height position where the mouth portion of the syringe can be pressed and deformed. Also in this disc-shaped seal valve, the upper surface and the lower surface of the disc-shaped seal valve can be constituted by various combinations of a planar shape, an arch-shaped concave shape, and an arch-shaped convex shape, as described in the seal valve and the rubber valve cover. .
さらに、上記各実施形態は、本発明を混注管に適用した場合について説明したが、薬液壜や薬液パックなどの容器や他の配管などにおいても、この注射器接続ポートを適用して、同様の作用効果を得ることができる。また、分岐管部分の数は、実施形態に示した1個だけでなく、複数個であってもよい。 Furthermore, although each said embodiment demonstrated the case where this invention was applied to a co-injection pipe | tube, this syringe connection port is applied also in containers, such as a chemical | medical solution container and a chemical | medical solution pack, and other piping, etc., and the same effect | action An effect can be obtained. Further, the number of branch pipe portions is not limited to one as shown in the embodiment, but may be plural.
1,1a〜1r 注射器接続ポート(ニードルレス混注管)
10 管本体
10a 薄肉部
10b 鍔部
11,12a 輸液チューブ接続口
13,14 分岐管部分
13a,14a 係合用凸部
15 スリーブ部
15a 係合用凹部
15b 段部
15c 螺合片
16 リング状固定具
16a 係合用凸部
16b 段部
20,21,22,23 シール弁
20a 受部
20b,21b,22b,23f 弁孔
21d リング部
21e,22e 凹部
22d 平坦部
25a 平坦面
30,31〜38 キャップ
30a,31a〜38a 係合用凸部
30b,31b〜34b,35d,36d 凹円弧状部
30c,31c〜34c,35b〜38b スリーブ部
30d,31d〜34d,35c〜38c 螺合片
31e〜34e,35d〜37d 鍔部
35a 係合用凹部
40 ツイストロック式ニードルレス注射器
44 口部
45 カラー部
46 雌ねじ部
50〜59 ゴム弁カバー
50c〜58c,59g 貫通孔
58a 円筒部
59a 略円筒状部材
59b キャップ状部材
60〜65 シール弁
60a,61e,62d,63e,64a,65a クッション部
60b〜63b,64c,65c 頭部
60d,61d,62c,63d,64e,65f 弁孔
1,1a-1r Syringe connection port (needleless mixed injection tube)
DESCRIPTION OF SYMBOLS 10 Pipe | tube main body 10a Thin part 10b Eaves part 11, 12a Infusion tube connection port 13, 14 Branch pipe part 13a, 14a Engaging convex part 15 Sleeve part 15a Engaging concave part 15b Step part 15c Screwing piece 16 Ring-shaped fixing tool 16a Engagement Joint convex portion 16b Step portion 20, 21, 22, 23 Seal valve 20a Receiving portion 20b, 21b, 22b, 23f Valve hole 21d Ring portion 21e, 22e Recessed portion 22d Flat portion 25a Flat surface 30, 31-38 Cap 30a, 31a- 38a Engaging convex portion 30b, 31b to 34b, 35d, 36d Concave arc-shaped portion 30c, 31c to 34c, 35b to 38b Sleeve portion 30d, 31d to 34d, 35c to 38c Screwed piece 31e to 34e, 35d to 37d 35a Concave part for engagement 40 Twist lock type needleless syringe 44 mouth part 45 Collar portion 46 Female thread portion 50 to 59 Rubber valve cover 50c to 58c, 59g Through hole 58a Cylindrical portion 59a Substantially cylindrical member 59b Cap-shaped member 60 to 65 Seal valve 60a, 61e, 62d, 63e, 64a, 65a Cushion portion 60b to 63b, 64c, 65c Head 60d, 61d, 62c, 63d, 64e, 65f Valve hole
Claims (2)
前記容器または配管の開口部を囲むように設け、シール弁を押圧して弁孔を圧着密閉する、ツイストロック式ニードルレス注射器の口部が挿入可能なスリーブ部と、
前記ツイストロック式ニードルレス注射器の口部をスリーブに挿入した状態において、その口部の先端をシール弁に貫通させることなく、かつ、その口部の先端で直接前記シール弁を押圧変形させて、シール弁の弁孔を開口させるようにしたことを特徴とする注射器接続ポート。 A substantially hemispherical seal valve made of an elastic material having a valve hole at the center, attached to the opening of a container or pipe;
A sleeve part that is provided so as to surround the opening of the container or pipe, presses the seal valve, and crimps and seals the valve hole; and a sleeve part into which a mouth part of a twist lock type needleless syringe can be inserted;
In the state where the mouth of the twist lock type needleless syringe is inserted into the sleeve, without causing the tip of the mouth to penetrate the seal valve, and directly deforming the seal valve at the tip of the mouth, A syringe connection port characterized by opening a valve hole of a seal valve.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004106042A JP4000125B2 (en) | 2002-08-06 | 2004-03-31 | Syringe connection port |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002228757 | 2002-08-06 | ||
JP2004106042A JP4000125B2 (en) | 2002-08-06 | 2004-03-31 | Syringe connection port |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003003570A Division JP2004195180A (en) | 2002-08-06 | 2003-01-09 | Syringe connection port |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2004209278A JP2004209278A (en) | 2004-07-29 |
JP4000125B2 true JP4000125B2 (en) | 2007-10-31 |
Family
ID=32827430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004106042A Expired - Fee Related JP4000125B2 (en) | 2002-08-06 | 2004-03-31 | Syringe connection port |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4000125B2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009172099A (en) * | 2008-01-23 | 2009-08-06 | Fukai Kogyo Kk | Medical seal valve |
JP2014117461A (en) * | 2012-12-17 | 2014-06-30 | Fukai Kogyo Kk | Coinjection tube |
WO2015168268A1 (en) * | 2014-04-30 | 2015-11-05 | Massachusetts Institute Of Technology | Adaptor for removal of fluid from vial using a needle-free syringe |
CN107536711B (en) * | 2016-06-24 | 2024-05-31 | 雷诺丽特恒迅包装科技(北京)有限公司 | Combined cover |
JP2020116338A (en) * | 2019-01-28 | 2020-08-06 | 株式会社トップ | connector |
US12023462B2 (en) * | 2022-09-29 | 2024-07-02 | Carefusion 303, Inc. | Fluid connector system |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6183448B1 (en) * | 1994-06-20 | 2001-02-06 | Bruno Franz P. Mayer | Needleless injection site |
CN1915451A (en) * | 1996-12-16 | 2007-02-21 | Icu医学有限公司 | Positive flow valve |
US6706022B1 (en) * | 1999-07-27 | 2004-03-16 | Alaris Medical Systems, Inc. | Needleless medical connector with expandable valve mechanism |
JP2001170187A (en) * | 1999-12-17 | 2001-06-26 | Terumo Corp | Connector |
-
2004
- 2004-03-31 JP JP2004106042A patent/JP4000125B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2004209278A (en) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4064422B2 (en) | Seal valve for medical device, connection port, mixed injection tube, infusion circuit connection device, and infusion circuit connection system | |
AU2010208667B2 (en) | Dual sealing system for use with a probe | |
KR101160278B1 (en) | Connector for medical liquid-containing packages and medical liquid-containing packages | |
AU2009248474B2 (en) | Port closure system for intravenous fluid container | |
US5971181A (en) | Multiple use universal stopper | |
US5569235A (en) | Valve and valved container for use with a syringe fitting | |
EP1211184B1 (en) | Cap for container and adaptor for liquid communication | |
US20130306169A1 (en) | Device for withdrawing liquid from a container | |
NO310805B1 (en) | Medical valve | |
EP2867132B1 (en) | A bottle for pharmacological and/or nutritional active substances | |
US20110022024A1 (en) | Connector for packaging containing medical fluids and packaging for medical fluids | |
CN101600411A (en) | Be used for the closing cap of the container that a receiving medical liquids uses and be used for the container of receiving medical liquids | |
KR20110067023A (en) | Connector with membrane to connect syringe to container or tube | |
US12292125B2 (en) | Umbrella check valve assembly having retention plate | |
US11464707B2 (en) | Connector for a medical package containing a liquid | |
JP4000125B2 (en) | Syringe connection port | |
CA3002966A1 (en) | Septum that decontaminates by interaction with penetrating element | |
JP2004195180A (en) | Syringe connection port | |
KR20070092974A (en) | New device | |
US20040241785A1 (en) | Device for microbiological examination of a sample of liquid under pressure | |
JP4044890B2 (en) | Medical sliding on-off valve | |
JP4056746B2 (en) | Syringe connection port | |
JP2004000463A (en) | Syringe connection port | |
JP2004033360A (en) | Syringe connection port for infusion | |
JPH08224315A (en) | Connecting device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20051206 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051212 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070130 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070402 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070719 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070810 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4000125 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100817 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110817 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110817 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120817 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120817 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130817 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |